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ABSTRACT
QUALITY OF LIFE FOR WOMEN WITH CHRONIC LYME DISEASE:
A SOCIOECONOMIC INVESTIGATION
MAY 2022
B.A., UNIVERSITY OF MASSACHUSETTS AMHERST
M.Ed., UNIVERSITY OF MASSACHUSETTS AMHERST
Ed.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Linda Griffin
This is a mixed methods investigation of how chronic Lyme disease, including Lyme-like
diseases and co-infections, affects the quality of life of women who have chronic Lyme.
Both quantitative and qualitative methods were used during three phases of research: a
91-question survey instrument followed by focus group discussions and written
narratives. The research considered the socioeconomic impact on quality of life in five
areas: obtaining a diagnosis, relationships and personal support systems, struggles with
the medical system, the ability to work, and access to treatment. There were 500
responses to the survey, of which 373 were analyzed; 11 participants in the focus groups;
and 22 written narratives. The data collected during the quantitative phase supported the
design of the qualitative phases and added validity to the findings. The research
demonstrated that chronic Lyme disease has a predominantly negative impact on
women’s quality of life across all five domains. Among the consequences highlighted by
the survey responses were difficulty obtaining a timely diagnosis (72% had multiple
misdiagnoses before being diagnosed); stressed relationships (57% reported that family
and friends do not understand the impact of the disease); difficulty securing appropriate
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treatment (86% indicated that primary physicians did not know numerous treatment
options); adverse impact on professional lives (75% reported that Lyme interfered with
their ability to work); and difficulty finding and paying for treatment (54% did not see a
specialist due to affordability). Through collecting and analyzing the data, it also became
increasingly apparent that the medical industry operates in a way that does not believe
chronic Lyme disease exists. In both focus groups and narratives, most participants
recounted experiences of repeatedly having their concerns and symptoms trivialized,
dismissed, or disbelieved by health care providers; the combination of deteriorating
health and gaslighting led to a sense of worthlessness, feelings of hopelessness, episodes
of depression, and more. Financial stability and relationships suffered, sometimes with
devastating impact. While my own struggle with chronic Lyme disease was the impetus
for this study, the research findings demonstrate how pervasive and deep the challenges
are, with consistently negative socioeconomic consequences for women’s quality of life.
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PREFACE
On August 30, 2008, my world was shattered, literally and figuratively, when I
had a near-fatal bicycle accident in which I sustained multiple skull fractures resulting in
a brain injury, as well as facial fractures and numerous other injuries. That was just the
beginning of a long and arduous journey into my medical nightmare. Concurrently, until
2014, I suffered from symptoms of chronic Lyme disease and the co-infection Bartonella
(cat-scratch fever) that went repeatedly undiagnosed. From the onset of symptoms to
finally having a diagnosis and treatment, managing my Lyme symptoms took a
tremendous toll.
Although I remember being bitten by ticks in the early 1980s and a handful of
times subsequently, I believe I was born with Lyme disease. Midelveen et al. (2014)
propose that there is strong scientific data suggesting that Lyme disease can be
transmitted in utero. Additional family history deepened my suspicions. My father was a
Korean War veteran and, as Newby (2019) writes, “soldiers were coming back from the
Korean War battlefields with strange infectious diseases” (p. 35). My father’s medical
issues and cardiovascular problems align with prominent Lyme symptoms. Moreover, I
had rheumatic fever as a child and, when I was twelve years old, I was diagnosed with
juvenile rheumatoid arthritis. Prior to my Lyme diagnosis I had cardiomegaly (an
enlarged heart) and high blood pressure. I also had anxiety from a young age, another
Lyme symptom. The list of medical issues grew dramatically throughout my childhood
into adulthood.
My Lyme infection, long kept in check by my strong immune system, did not
become a full-blown diagnosable disease until after that near-fatal bicycle accident in
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2008. Often, Lyme symptoms become fully obvious only after a traumatic event, as was
certainly true in my case. Anecdotally, I have spoken with several individuals whose
symptoms appeared suddenly after trauma (e.g., a divorce, accident, or operation),
reinforcing my belief that the onset of full-blown Lyme can be triggered by a distraction
to the immune system. I call this phenomenon the “Lyme explosion.” Although there are
no direct studies on this specifically, Horowitz (2013) states, “The mind and body do not
function separately, and when patients have had trauma or been abused, or if they suffer
loss with unresolved grief, the unresolved conflict usually has a deleterious effect on their
immune system” (p. 325). He further suggests trauma can precipitate immune system
failure (p. 325). Given these experiences, it seems appropriate to say that the distraction
to the immune system hypothesis warrants attention.
For the first seven years after the accident, after my most immediate symptoms
from the traumatic brain injury and other injuries subsided, I had a variety of seemingly
unrelated symptoms—elevated blood pressure, a goiter in my neck, intense dental pain,
hypothyroidism, and persistent random rotating body aches—that necessitated my
making at least 25 to 30 visits to see a doctor. It was never suggested to me that I might
have Lyme and, consequently, I was never tested. My health was deteriorating daily, but
it was not until I acquired a Lyme symptoms checklist from a friend that I reviewed my
medical history from that vantage point, and realized my symptoms matched many of the
ailments on the checklist. These were complicated medical issues for which I had sought
treatment most of my life, with only limited results, the equivalent of putting on a “bandaid.” But even when I presented my primary physician with a list of my symptoms (66 of
them), she refused to treat me for Lyme.
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Once I realized the likelihood of a longstanding Lyme infection, I sought testing,
and a positive ELISA (antibody test) panel confirmed the diagnosis. I referred myself to a
specialist and, since 2014, I have been treated with both conventional pharmaceuticals
(antibiotics) and a primarily naturopathic protocol. Lyme disease continued to dominate
my life for the better part of the next four years. The treatment causes a toxic reaction
known as the Herxheimer reaction (often called “Herx” for short), which occurs as
bacteria from Lyme and associated co-infections are killed off. In my case, the reaction
was severe and sustained. I was bedridden for periods of time, unable to work, and
frequently could not drive or walk, necessitating that I use a wheelchair and/or rely on a
driver. I changed my diet to one that was strictly no sugar, yeast, or alcohol; I basically
survived on eggs, chicken, and broccoli. Changing food habits was the easy part.
Financially, the cost was devastating, I chose a natural path to treatment augmented by
minimal pharmaceuticals; the former was not covered by health insurance. Each month I
would travel four hours to see my naturopathic specialist in Vermont, paying $400 to
$700 for each visit and the associated herbal medicines and supplements. Hiring people
to drive me for appointments and errands cost hundreds of dollars more per month. My
best friend became my Lyme advocate, and I would have my driver pick her up to go
with me to medical appointments.
Thank goodness I have a strong will; Lyme is not for the weak of spirit. On the
worst of days, I wanted to die, and on the best of days, I was happy if I could take a
shower. There was a new normal to my existence: order groceries online, mix doses of
medicine to take four times daily, stay in bed and hope to make it through the day, take
my blood pressure and be grateful if I could walk to the bathroom. My social life, athletic
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pursuits, and romantic hopes all disappeared. An extrovert, I had been physically active
and very social for my entire life. Now, if I dared to make plans, I had to preface my
arrangements with, “If I am sick or having a bad day, I will not be able to make it.” I lost
a few friends that way because they could not tolerate the last-minute changes. With
invisible illnesses, people do not necessarily accept how sick you are: they see you as
functional. Some, including some medical professionals, do not believe we “Lymies” are
as sick as we profess, and dismiss or diminish our experience.
Over time my health has been significantly restored, except for occasional flares,
which can be debilitating for periods of time, and persistent symptoms that never subside.
But knowing that Lyme will never fully go away, I am committed to advocating for
others seeking to understand and treat this insidious disease. I have many friends and
colleagues who suffer from Lyme. Many are successfully treated, many are just getting
started in understanding their symptoms and treatment options, and many are in the midst
of suffering. I speak with people on this subject almost daily, providing advice and
support. It is not uncommon for me to get unsolicited phone calls, strike up random
conversations that lead to a Lyme discussion, or receive messages seeking guidance. I
frequently refer people to my naturopathic specialist, who has treated more than 1,000
Lyme patients, and to Igenex lab for testing. There is a host of resources available
through the International Lyme and Associated Diseases Society (ILADS), local
advocacy centers, and a variety of grassroots Facebook groups.
*

*

*

It was approximately 2016, and I was having breakfast with a professor from my
previous doctoral work, Dr. Gretchen Rossman. We were discussing my lack of academic
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pursuits since receiving my doctorate in education in 2004. We were also talking about
my diagnosis of and battle with chronic Lyme, and how many people suffer from this
invisible disease. When I expressed my frustration at not being able to utilize my
academic credentials, she off-handedly said, “Write a book.” I asked her, “What about?”
and she said, “Lyme.” I replied, “Will you co-author it with me?” From that breakfast
meeting the idea for the book, Bitten by Lyme, was born. We met many times thereafter
to formulate and refine the idea.
One of our discussions led to Dr. Rossman suggesting I investigate an innovative
program at the University of Massachusetts Amherst that allows someone with an EdD to
get a PhD, with some of the previous doctoral credentials counting toward the new
degree. This was an intriguing idea, as it would enable me to conduct this research and
write this dissertation in pursuit of an advanced degree, as opposed to simply writing a
book about Lyme. It would allow me to access up-to-date research and network with
scholars. Being in the academy would allow me to convey the information more broadly.
Moreover, I was already designing a survey with colleagues for data collection about
chronic Lyme disease, which was being developed and implemented while I was
applying to this program.
The other significant factor that encouraged my decision to pursue a PhD was the
ability to work closely with colleagues at the University whose work I value and respect:
Dr. Daniel Gerber, then Associate Dean of the School of Public Health and a colleague
from my first doctoral program; and Dr. Linda Griffin, then Associate Dean for
Academic Affairs. They are my dissertation committee, along with Dr. Rossman. I am
incredibly fortunate to have these accomplished faculty members on my team.
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This dissertation is organized into five chapters. Chapter 1 introduces the reader
to the dissertation by providing an overview of the subject matter, a statement of the
purpose underlying the research, and a discussion of its potential significance. It also
introduces the research questions, describes how the study was structured, addresses
ethical considerations in conducting research, and acknowledges the limitations of the
study. As such, this chapter identifies the rationale for the study and why the methods I
chose are particularly well suited to the subject matter.
Chapter 2 presents the literature review. It offers historical and contextual
information, explanation, and critique. The broad issue of quality of life and chronic
illness is discussed and subsequently narrowed down to women with chronic illness and,
further, women with chronic Lyme disease, Lyme-like diseases, and co-infections. A
study conducted by Johnson et al. (2014), “Severity of chronic Lyme disease compared to
other chronic conditions: A quality of life survey,” is examined in detail. Some
theoretical perspectives are included and several studies relevant to the topic are
investigated. The lack of subject-specific research articles and literature is discussed, as
well as the sparsity of academic investigation into this issue.
Chapter 3 details the design and methods I selected for this research project. Both
quantitative and qualitative methods are discussed and the appropriateness of a mixed
methods approach is reviewed, including with regard to trustworthiness, validity, and
generalizability. This chapter also reviews the utility of surveys, phenomenology, and
narrative as research genres for this study, and outlines the sequencing of the research
phases and the specific data-gathering strategies I followed.
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In Chapter 4, an in-depth analysis of findings from each of the three phases of
research is presented. This chapter weaves together the quantitative and qualitative
dimensions of the study for a comprehensive portrayal of how the five research topics
manifest themselves in the lives of women with chronic Lyme disease. This chapter
includes brief biographies of some of the women who participated in the focus groups
and narrative assessments, reflecting that many of their experiences are consistent but
they also are on individual journeys.
Finally, Chapter 5 provides on a summation of the findings, a discussion of the
implications and challenges, suggestions for future research directions, and conclusions
about the need for fundamental changes at the medical industry and policy levels to
diagnose, treat, and support women who have had their quality of life so deeply altered
by chronic Lyme disease. This chapter also introduces my goals and intentions for future
work to bring such changes about.
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CHAPTER 1
QUALITY OF LIFE AND CHRONIC DISEASE
Rationale, Scope, and Purpose
In recent decades, quality of life (QoL) has become a significant indicator of
public health for major health institutions such as the United States Centers for Disease
Control and Prevention (CDC) and the World Health Organization (WHO). The CDC
(2018b) defines QoL as “a broad multidimensional concept that usually includes
subjective evaluations of both positive and negative aspects of life” (section: What is
quality of life?). It includes health, employment, housing, schools, and the physical
environment. The WHO (2012) introduces an additional element: “individuals’
perceptions of their position in life in the context of the culture and value systems in
which they live and in relation to their goals, expectations, standards and concerns”
(section: Summary of WHOQoL instruments). QoL includes both quantifiable and nonquantifiable variables, from sufficient income, to access to adequate healthcare, to one’s
level of life satisfaction.
Chronic diseases have the potential to severely disrupt any of those variables that
constitute QoL. According to the Institute of Medicine (2012), chronic disease or illness
is one that is often “slow in progression [and] long in duration,” unlikely to resolve, and
limits productivity and quality of life (p. 1). As of the date of this writing, we are entering
the third year of a global pandemic of COVID-19. This disease has changed the world as
we once knew it to be. An article published by the World Health Organization (2020)
states “The COVID-19 pandemic has led to a dramatic loss of human life worldwide and
presents an unprecedented challenge to public health, food systems and the world of
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work.” COVID-19 will have a huge impact on the quality of life for many, especially as
“long COVID” is increasingly recognized as a chronic, debilitating condition (CDC,
2021d).
Managing a chronic illness requires frequent monitoring by a multidisciplinary
team: regular visits to a healthcare provider, lab work or imaging studies at set intervals,
patient education, and care coordination. Countless hours that could be used to further an
individual’s productivity or creativity are instead spent attending to the medical
condition. Unemployment, loss of relationships, unaffordable medical bills,
stigmatization, and loneliness are all consequences of chronic disease, undermining wellbeing and quality of life. There are societal costs as well. Chronic disease management
imposes a significant financial burden on the US health care system. The Centers for
Medicare and Medicaid Services (2010) reports that chronic diseases are responsible for
70% of the deaths of all Americans and account for 75% of US health care costs overall.
Indisputably, chronic illness often leads to disruptive and devastating life
alterations, affecting not just one’s health but also one’s overall well-being. Research has
shown that women with chronic illnesses experience isolation accompanied by a host of
other negative life impacts from being ill (see, e.g., O’Neill, 2008; Warner, 2019).
Women spend a great deal of time and money dealing with their health issues; at the
same time, their relationships can be significantly stressed and even fail due to the
consuming nature of managing a chronic condition. Other significant issues women may
grapple with are loss of employment, extreme medical bills, poor treatment,
stigmatization, and loneliness, to name a few. Thus, my purpose for this dissertation was
to ask: How does chronic Lyme disease affect the quality of life and socioeconomic
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circumstances of the women who have it? And second: How do the misunderstanding,
misrepresentation, mistreatment, and misdiagnosis that often typify women’s experience
of Lyme disease and associated conditions affect their quality of life and particularly their
social and economic well-being?
Initially, I did not plan to focus my research exclusively on women. However, as
a participant in the Women and Lyme Disease Group, a popular social media group that
uses Facebook as its platform, I had access to an appropriate audience. The group serves
as a valuable source of information, support, and resources for its members. At the time I
began this research, the group had 18,000 members, mostly from the United States with a
smattering of international members; it now has 22,000 members. Having ready access to
such a large number of women with Lyme and Lyme-like diseases (LLDs) 1 through this
site made it was an obvious choice to concentrate my research on women. I was also
persuaded by the evidence that women are more likely to seek medical assistance, a
reality that supports the intentions of this research. According to a National Center for
Health Statistics press release (CDC, 2001), “Even excluding pregnancy-related visits,
women were 33 percent more likely than men to visit a doctor, although this difference
decreased with age. The rate of doctor visits for such reasons as annual examinations and
preventive services was 100 percent higher for women than for men.”
As noted above, chronic illness carries with it significant and deleterious effects
on QoL overall, and most of the women investigated through this research have had
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I use Lyme disease as an umbrella term that encompasses Lyme-like diseases. There are
at least 16 known co-infections that can accompany Lyme disease—Bartonella, Babesia,
Rocky Mountain Spotted Fever, and the like—but for the purposes of this dissertation
research, differentiating between them was not significant. All study participants were
made aware that Lyme disease was used as an inclusive term.
3

significant alterations to their lives. In addition, women with chronic conditions face
other, unique challenges as they work to manage their health issues, cope with financial
stressors, and keep their families intact. Many have lost jobs, have been separated from
family and children, and have seen a horrible decrease in their quality of life. The
misunderstanding, misrepresentation, mistreatment, and misdiagnosis that can
accompany Lyme disease and co-infections compound these challenges still further.
This study, therefore, was not intended to be a health-related metric, such as the
CDC uses. Instead, my intention was to consider the social and economic impacts of
Lyme disease on the quality of life for women with chronic Lyme. Specifically, my
purpose was to design, conduct, and analyze this research with the intention of publishing
my dissertation as a book, and to provide detailed information to a broad audience on
how chronic Lyme has a severe impact on women’s quality of life, in myriad ways.

Significance
Three questions posed by Rossman and Rallis (2012) shaped my approach in
considering the significance of this study:
1. Who has an interest in this inquiry?
2. How will my research add to theory, policy, and practice? And,
3. How might it benefit the participants and be significant to them? (p. 132)
Lyme disease has reached epidemic proportions in the United States and is on its
way to becoming a global crisis. According to Johnson et al. (2014), “Lyme disease is the
most common vector borne disease [from a blood feeding insect, i.e., the deer tick] in the
United States” (p. 2). At the same time, Lyme disease as a chronic condition is debated
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by many medical and non-medical specialists, hotly contested as to its existence and
chronicity. Aronowitz (2015) succinctly sums it up: “Nearly every aspect of the
diagnosis, treatment, and prevention of Lyme Disease has been fiercely contested” (p.
111). My assertion is that, in part because of this debate and confusion about chronic
Lyme disease, the medical community, policy makers, and health providers, as well as
patients, will be interested in this inquiry. For instance, in 2019, a colleague and I
presented our survey research findings at the International Lyme and Associated Diseases
Society’s conference. The information was so well received that a well-known Lyme
disease specialist (and former executive director of the Society) invited us to his clinic in
New York to begin a collaboration.
As is evident in the popular press, Lyme is becoming increasingly visible and,
with it, awareness of its impact. Official estimates of the numbers of people infected each
year range up to 476,000 (CDC, 2021b). Medical professionals now provide “what-to-doif-bitten” advice on a regular basis. Public health officials warn that the deer tick is
spreading into regions where it was previously unknown. High profile public figures such
as Alec Baldwin (actor), Amy Tan (best-selling author), Jennifer Caprioti (tennis
champion), Ben Stiller (actor, comedian, and filmmaker), Richard Gere (actor and
humanitarian activist), and Justin Bieber (pop music icon), among others, have
announced that they have been afflicted. Singer-songwriter Avril Lavigne became so
seriously ill from chronic Lyme that she was impelled to start a Lyme disease foundation.
Increasing awareness of chronic Lyme disease on multiple levels was inherent to
the significance of conducting this research. With growing public awareness, people who
are suffering may find emotional, logistical, and financial support. With further public
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awareness, people may become more vigilant about tick bites and therefore able to
protect themselves more effectively. And with more public awareness, increased funding
may become available to conduct research on the spread of the disease and help mitigate
the symptoms of Lyme. Last, perhaps a solid, well-paved road to proper diagnosis and
treatment will finally replace the patchwork approach we see today.
Another significant dimension of this research is that its focus is on measuring
Health Related Quality of Life (HRQoL) among women with chronic Lyme. Public
health’s traditional approach to tracking disease relies on measures of morbidity and
mortality but, as noted by the CDC (2018e), “recent federal policy changes underscore
the need for measuring HRQoL to supplement public health’s traditional measures of
morbidity and mortality” (section: Why is it important to track HRQoL?). Investigating
HRQoL issues for women with Lyme disease is essential both for individual and more
systemic reasons. According to Megari (2013), HRQoL studies regarding chronic illness
have shown that “the impact of chronic diseases on HRQoL can make health services
more patient-centered” (p. 4). Further, conducting HRQoL studies allows a patient’s
voice to be heard. He additionally suggests that studies of HRQoL in chronic diseases are
essential to “develop interventions” that “strengthen public health actions” and aid with
daily care of patients (p. 13). It is my hope that emphasizing questions of quality of life
will help practitioners appreciate and address the views and experiences of their patients
with chronic Lyme, leading to a better quality of care.
Finally, this research offers a fresh and distinct perspective on chronic Lyme
disease and related co-infections through its grounding in social science research. Most
literature on chronic Lyme disease falls into one of three categories: personal stories,
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“how-to” books about disease management, and technical medical research. There are
many moving accounts about individual struggles with diagnosis and treatment of
chronic Lyme, including the profound impact of the disease on families’ lives, among
them: Why Can’t I Get Better? (2013) and How Can I Get Better? (2017), by Richard
Horowitz; Believe Me: My Battle With the Invisible Disability of Lyme Disease (2017),
by Yolanda Hadid; Bite Me: How Lyme Disease Stole my Childhood, Made me Crazy,
and Almost Killed Me (2016), by Ally Hilfiger with a forward by her father, Tommy
Hilfiger; and Lyme Madness: Rescuing my Son Down the Rabbit Hole of Chronic Lyme
Disease (2016), by Lori Dennis. In the how-to genre, we find works by medical
professionals, such as Unlocking Lyme: Myths, Truths, and Practical Solutions for
Chronic Lyme Disease (2017), by William Rawls, MD; Lyme Brain: The Impact of Lyme
Disease on your Brain, and How to Reclaim your Smarts (2016), by Nicola McFadzean
Ducharme, MD; and The Lyme Disease Solution (2008), by Kenneth Singleton, MD.
This dissertation fills a gap in the literature and provides a unique perspective by
combining quantitative and qualitative social science research methods. A mixed
methods approach was optimal for capturing the complexity of women’s experience with
chronic Lyme disease relative to their quality of life because it incorporates survey data
together with individual accounts gleaned from focus groups and written stories. My aim
was both to paint a scientific portrait and create a compelling narrative.
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Research Questions, Topics, and Phases of Research
This dissertation investigates the impact of chronic illness on health-related
quality of life (HRQoL) 2 for women who are suffering from the effects of chronic Lyme
disease. I approached this research with one overarching question: How does chronic
Lyme disease, including Lyme-like diseases and co-infections, affect the quality of life of
women who have it? My secondary questions were:
1. What are the experiences of the women who have chronic Lyme disease?
2. What are the major QoL issues women with chronic Lyme disease face? And
3. What are the socioeconomic obstacles created from having chronic Lyme disease?
Identifying the important questions to ask, and the best ways to ask them, was a
challenge. As Rossman and Rallis (2012) note, “research questions are critically
important for guiding your work” (p. 132). Research should make an impact, and the
questions guide the discovery.
To investigate QoL, it is important to understand a person’s well-being status, and
therefore this research was designed in alignment with the CDC’s (2018d) definition of
well-being:
[W]ell-being includes the presence of positive emotions and moods (e.g.,
contentment, happiness), the absence of negative emotions (e.g., depression,
anxiety), satisfaction with life, fulfillment and positive functioning. In simple
terms, well-being can be described as judging life positively and feeling good. For
public health purposes, physical well-being (e.g., feeling very healthy and full of
energy) is also viewed as critical to overall well-being. Researchers from different
disciplines have examined different aspects of well-being that include the
following:
• Physical well-being.
• Economic well-being.
2

I use quality of life (QoL) as the general term to identify the characteristics of a
comprehensive life assessment, both exclusive and inclusive of illness, and health-related
quality of life (HRQoL) to focus on the specific impact of disease.
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•
•
•
•
•
•
•

Social well-being.
Development and activity.
Emotional well-being.
Psychological well-being.
Life satisfaction.
Domain specific satisfaction.
Engaging activities and work. (section: How is well-being defined?)

This definition makes clear that the physical, mental, and social aspects of the
lived experience are all important to being a successful, vibrant, and productive member
of one’s chosen society. Well-being includes the assumption that one’s life will have a
large percentage of time free from the inconveniences and stresses of chronic illness. As
noted by the Institute of Medicine (2012), “chronic disease has now emerged as a major
public health problem, and it threatens not only population health but also social and
economic welfare” (p. 2). More specifically, Patrick and Erickson (1993) define HRQoL
as “the value assigned to duration of life as modified by the impairments, functional
states, perceptions and social opportunities that are influenced by disease, injury,
treatment or policy” (p. 3).
In addition, five major research topics informed this research. Having personal
experience with Lyme and having faced an inordinate number of challenges of my own, I
set out to examine the specific experiences of other women with the disease in the
following areas:
1. Diagnosis;
2. Relationships;
3. Medical Struggles;
4. Work ability; and
5. Access to treatment.
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This investigation followed a research protocol consisting of three phases, each of
which was shaped by a concentration on the five topics delineated above. Phase I was
quantitative: a research survey I conducted in 2019 to collect data on the socioeconomic
impacts of Lyme disease and its effects on women’s quality of life. For this portion of the
research, I was supported by a team consisting of a university professor, a general
practitioner/MD, a psychometrics PhD student, a research consultant, and a statistics PhD
student to create and conduct the survey. I also relied on the counsel of an advisory board
I recruited, comprising an educational researcher not affiliated with the University, a
neurologist with a great deal of Lyme expertise, a Lyme-literate naturopathic physician,
and a social media coordinator (who is also a Lyme patient and advocate). The survey
was distributed to a Facebook group of over 18,000 women with Lyme disease and data
were tabulated and analyzed twice by statisticians and researchers with different
disciplinary concentrations, allowing for in-depth analysis.
Phases II and III were qualitative and were formulated to elaborate on the survey
results: collecting qualitative data about women’s experience of chronic Lyme and how it
affects quality of life allows for more accurate and individual information to support the
quantitative data, and vice versa. Phase II was phenomenological and involved convening
a series of five guided focus groups to explore more precisely each woman’s road to
diagnosis of chronic Lyme disease, the attendant financial burdens, and the resultant
relationship impacts. Within each focus group, participants were asked to elaborate in
detail concerning their journey with one of the five research topics. (The focus group
sessions and follow-up discussions were conducted via Zoom due to COVID-19
pandemic constraints.)
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Phase III used a narrative genre: I solicited narratives from women (not
necessarily the same women who responded to the survey) who have chronic Lyme
disease, asking them to anonymously submit stories via the study website
(www.bittenbylyme.com). The website outlines the research and direction of the planned
book and provides guided topics for written responses. These stories detail the journeys
of women who have faced the challenges of navigating life while having chronic Lyme
disease. A selection of their qualitative stories are intertwined with the quantitative data
to present a compelling mixed-genre inquiry.

Ethical Considerations
The Institutional Review Board (IRB) process ensures the ethical treatment and
protection of human research subjects. The IRB at the University of Massachusetts
Amherst reviewed and approved the three phases of this study—protocol ID 2560—as
documented in Appendix A. IRB approval was obtained twice: first for the Phase I
survey (quantitative data); and second for the Phase II focus groups and Phase III
narrative compilation (both qualitative data). The protocol outlined the framework of the
research, addressed academic rigor, detailed what would be asked of study participants,
and provided the informed consent document to be distributed to participants.
The informed consent documentation provided to participants detailed the
research and its intended purposes, explained steps to protect participants’ confidentiality,
discussed the scholarly nature of the work, and noted that the data would eventually lead
to publication(s) intended to expand knowledge about and shed light on Lyme disease
and its effect on women’s lives. It also conveyed the hope that the study would benefit
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participants indirectly by validating their experiences and contributing to the broader
psychological and social understanding of the impacts of Lyme disease. Specifically, the
consent form for the study included the following disclosures:
•

There will be no financial compensation or direct benefit for participation;

•

Participation in this study can carry psychological risk as questions are related to
the impacts of Lyme disease and Lyme-like diseases on one’s personal life, social
life, and workplace, and may elicit negative memories; and

•

There are no other known risks associated with participation in this study.

The informed consent also disclosed the procedures that would be followed to protect the
confidentiality of study records:
•

Individual responses will be confidential, and files will be de-identified;

•

Only the researchers will have access to the data;

•

Names, birth dates, and addresses will not be recorded;

•

Responses will be averaged with others fitting similar demographic profiles and
the responses of sole individuals will not be published; and

•

Any computer hosting electronic files will have password protection to prevent
access by unauthorized users and any physical copies will be kept in a secure
location.
All potential study participants were also informed that the researcher has a

personal engagement with the topic, experience in the Lyme disease community, and
experience with the effects of the disease. It was determined by the research team as well
as the academic committee that there was not a conflict of interest in this matter. The
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study’s participants were enthusiastically receptive to the investigator’s personal
commitment to the issue.
Finally, the www.bittenbylyme.com website was created so that participants could
access background information and ongoing details about the research in real time.

Limitations
One limitation of this study was sample size. A larger sample is always better;
according to Locke et al. (2010), “In general the higher the number in the sample for a
study, the greater the likelihood that what is observed in the subjects approximates what
could be observed in the total population” (p. 162). As discussed in Chapter 3, the target
sample size for the Phase I survey was 500 responses. However, given the size of the
population surveyed, this investigation could have benefitted from a larger sample.
Additionally, in the analysis, it became evident that some items were ambiguous, and the
survey could have included additional items to round out the analysis. Notwithstanding
these limitations, Lyme and Lyme-like diseases constitute a growing public health crisis.
The survey was one small step in bringing rigorous quantitative data into the public
sphere; clearly, there are many further studies that can and should be done.
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CHAPTER 2
LITERATURE REVIEW
The examination of the literature I conducted in preparation for this research
highlighted several studies that used the CDC’s (2018c) HRQoL methods and measures
in relation to chronic illnesses. I also explored academic journal articles, books, websites,
and internet sites that are presented as resources directly relevant to chronic illness, Lyme
disease, QoL, and HRQoL. In approaching this review, I was not seeking the medical and
other literature that is most commonly available regarding the treatment and diagnosis of
Lyme disease; rather, I set out to find information specifically about women’s life
experiences while navigating chronic Lyme. Although my primary research focus was on
women and chronic Lyme, I also reviewed publications relevant to QoL experiences for
people with other chronic conditions.

Setting the Stage: Chronic Lyme Disease
This dissertation sought to explore the devastating reality of chronic Lyme disease
as a distinct medical condition, but it is important to acknowledge that this is a
controversial topic in the field of medicine. Lyme first became known in the mid-1970s,
when Polly Murray noticed a cluster of symptoms among members of her community in
Lyme, Connecticut, and brought it to the attention of public health officials. She and her
family were the first to be diagnosed with Lyme disease. Two decades later, she authored
a book about her experiences, noting that “too many people, even some in the scientific
field, still minimize the problem of Lyme disease” (1996, p. xi). Now that another 25
years have passed, Lyme disease is broadly accepted as a legitimate infection and short-
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term treatment is readily available. As described by the CDC (2020c), Lyme is an
infection that is relatively easy to diagnose and, when treated early, one that can usually
be rapidly and completely resolved with a curative course of antibiotics.
In contrast, the very existence of chronic Lyme disease is disputed by many in the
medical profession; the controversy is so intense that it is sometimes referred to as “the
Lyme wars.” There is some increasing recognition that the symptoms of Lyme can last
beyond the course of treatment, but the health impacts are still minimized and the larger
concept of chronic Lyme is often discounted. For example, the National Institute of
Allergy and Infectious Diseases website—in an entry reviewed as recently as November
2018—answers the question, “What is ‘chronic Lyme disease?’” as follows:
Lyme disease is an infection caused by the bacterium Borrelia burgdorferi. In the
majority of cases, it is successfully treated with oral antibiotics. In some patients,
symptoms, such as fatigue, pain and joint and muscle aches, persist even after
treatment, a condition termed “Post Treatment Lyme Disease Syndrome
(PTLDS).”
The term “chronic Lyme disease” (CLD) has been used to describe people with
different illnesses. While the term is sometimes used to describe illness in patients
with Lyme disease, it has also been used to describe symptoms in people who
have no clinical or diagnostic evidence of a current or past infection with B.
burgdorferi. Because of the confusion in how the term CLD is employed, and the
lack of a clearly defined clinical definition, many experts in this field do not
support its use. (NIAID, 2018)
In an exploration of the controversies attached to chronic Lyme disease, Maloney
(2016) wrote: “Dismissing the possibility of chronic infection, the Infectious Diseases
Society of America (IDSA) attached negative connotations to the term chronic Lyme and
discouraged its use” (section: Controversy 1: Establishing terminology for the condition).
She observed that both professionals and lay persons using that terminology were
“stigmatized,” adding that “patients who identified themselves as having chronic Lyme to
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physicians often reported being marginalized medically” (p. 370). Horowitz (2013),
speaking about the IDSA’s 2006 clinical practice guidelines wrote, “the IDSA guidelines
panel improperly ignored or minimized consideration of alternative medical opinion and
evidence regarding chronic Lyme disease, potentially raising serious questions about
whether the recommendations reflected all relevant science” (p. 13).
Appendix B provides more information about the history and evolution of Lyme
disease, and the controversies that surround it. But it is important to reiterate here that
medical skepticism only serves to further hamper the quality of life for those with chronic
Lyme disease.

Current Literature
This section presents a review of three components of relevant current literature:
literature on the quality of life, literature on chronic Lyme and the quality of life, and
literature on women with chronic illness. Additionally, it provides a summary of current
quality of life studies.

Literature on Quality of Life
Health-related quality of life research is important in a variety of ways to the
development of policy and treatment of illness, both chronic and acute. The Institute of
Medicine (2012) states that one in four Americans has more than one chronic condition.
According to Bayliss et al. (2012), “In the US, approximately 53% of adults have at least
one chronic condition” (section: Abstract) which can have a negative effect on many
aspects of their lives. Furthermore, according to Shofany (2017), “HRQoL measurements
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have become very important tools for medical researchers who wish to improve
treatments and practices” (p. 388).
To examine QoL, the CDC (2018a) developed the HRQoL-14 “Healthy Days
Measure” (provided in full as Appendix C). The HRQoL-14 consists of three modules—a
“Healthy Days Core Module,” with four questions; an “Activity Limitations Module,”
with five questions; and a “Healthy Days Symptoms Module,” also with five questions—
each of which has been in use as a public health instrument since the early- to mid-1990s.
According to Megari (2013), it is “a multidimensional construct that consists of at least
three broad domains—physical, psychological, and social functioning—that are affected
by one’s disease and/or treatment” (p. 141). The CDC (2018b) explains the utility of the
measure as follows:
The Healthy Days measures assess the burden of physical and mental health
problems that are not disease-specific. Data from the Behavioral Risk Factor
Surveillance System (BRFSS) and the National Health and Nutrition Examination
Survey (NHANES) on socioeconomic and demographic characteristics and the
Healthy Days measures have been used to quantify perceived physical and mental
health disparities among population subgroups on the basis of gender, race or
ethnicity, education, income, and place of residence. Therefore, health planners
and policy makers can use the measures and resulting data to help allocate
resources among competing health programs on the basis of several criteria
including the burden of impaired HRQoL in a specific group. Because of their
sensitivity to time trends, the Healthy Days measures are also likely to be useful
in determining the effect of major population-based policies or interventions.
(section: What are the policy implications of HRQOL surveillance?)
The HRQoL-14 is widely utilized as an assessment tool in many different clinical
contexts. Using this metric, Richardson et al. (2008) studied cancer survivors ages 24 to
60 who had activity limitations that affected their quality of life. They found that
participants had poorer health and more unhealthy days that consisted of more pain and
less sleep than was true for the group that had no activity limits. In another study
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conducted with the same CDC metric, researchers examined QoL for adults with acute
liver failure. Rangnekar et al. (2013) studied 1,850 adult men and women and found that
the patients “reported significantly more days of poor physical and mental health during
long‐term follow‐up in comparison with the general US population” (p. 998). The
consensus among researchers studying QoL for those with chronic conditions points to
the negative influences that illness has on a patient’s life.

Literature on Chronic Lyme and Quality of Life
The literature search revealed one relevant published article about chronic Lyme
disease and quality of life: “Severity of chronic Lyme disease compared to other chronic
conditions: A quality of life survey,” by Johnson, at al., published in PeerJ in 2014. The
study recounts the results of a quantitative survey measuring quality of life for
respondents with chronic Lyme disease. The researchers embarked on this study because
the CDC’s HRQoL measures, while used to assess quality of life with regard to many
chronic diseases, had not been applied to chronic Lyme. As they stated, “The purpose of
this study is to document the severity of CLD [chronic Lyme disease] compared to other
chronic conditions using the CDC HRQoL metric…To our knowledge, this is the first
study that examines these HRQoL indicators in persons with CLD” (p. 2).
Johnson et al. looked at the published data (e.g., Bayliss et al., 2012) on HRQoL
for individuals with self-reported chronic physical and/or mental health conditions from
2012. They also studied the literature (e.g., Moriarty et al., 2003) about self-reporting of
HRQoL and how the general population determines the symptom burden of their chronic
diseases, identifies their health disparities and their unmet health needs, and evaluates
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their progress on achieving goals, which in turn informs the government and other
entities of public health policy decisions.
Of the 5,357 subjects who participated in the Johnson et al. study via an online
survey instrument administered by Lymedisease.org, 3,090 were selected for analysis.
Respondents met the study’s criteria for chronic Lyme if they “have been clinically
diagnosed with Lyme disease, have the EM [erythema migrans] rash and/or have
supporting laboratory tests confirming the diagnosis, and have persisting symptoms for
more than six months following at least 21 days of antibiotic treatment” (p. 3). The
findings for these subjects were compared and contrasted to published findings about
HRQoL for the general population and for people with other chronic illnesses, such as
chronic back pain, diabetes, asthma, cardiovascular disease, and depression. They found
that “compared to the general population and patients with other chronic diseases, CLD
respondents reported significantly more bad physical and mental health days”; “high outof-pocket expenses compared with other diseases”; and “severe or very severe symptoms
related to fatigue, joint pain, headaches, other pain, muscle aches, neuropathy, cognitive
impairment, sleep impairment or mood impairment” (p. 13).
Study participants rated their overall health quality as “excellent,” “very good,”
“good,” “fair,” or “poor.” They were asked to evaluate their health during the previous
month, including number of days they experienced poor physical health, poor mental
health, depression, anxiety, difficulty sleeping, etc., as well as the number of days their
activities were restricted due to the discomfort they experienced. In determining what
symptoms to evaluate, Johnson et al. relied on information derived from previous Lyme
research studies as well as an earlier on-line survey. Other variables factored into the
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analysis included visits to doctors and other health specialists, visits to emergency
departments, inpatient care, and home care visits. Employment status due to health
impacts was tracked as well (pp. 5-7). Johnson and colleagues found that, in comparison
to the general population as well as others with chronic conditions, patients with chronic
Lyme disease reported “significantly lower health quality status, more bad mental and
physical health days, a significant symptom disease burden, and greater activity
limitations”; as well as difficulty with work, a heightened usage of health services, and
spending more on medical costs (p. 1).
Johnson et al.’s work has a number of structural similarities with this dissertation
research. The researchers note that their “sample is self-selected from participants who
are sick enough (and Internet-savvy enough) to seek online support for their illness” (p.
16). Likewise, the respondents to this dissertation’s research survey were a self-selected
sample and were adept at using technology. Self-reported information has been found to
have acceptable levels of reliability when compared to medical chart information (Bayliss
et al., 2012), and self-rating is a reliable strategy for reporting perceived health and
personal well-being.
Respondents to the Johnson et al. study reported experiencing many limitations on
their daily activities. Richardson et al. (2008) note that patients limited by a condition or
chronic illness may represent the most severely ill individuals with that condition. Along
these lines, participation in Johnson et al.’s survey was restricted to patients whose
persistent systems had lasted a minimum of six months. They concluded that “patients
with acute Lyme disease who are diagnosed and treated early would be expected to have
less quality of life impairment” (p. 16). This survey demonstrated comparable results.
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The high percentage of women in the Johnson et al. sample may reflect the
female-skewed demographics often seen in patient survey responses (Boscardin &
Gonzales, 2013; Stricker & Johnson, 2009). The reasons women were selected for this
research were their increased accessibility, the consensus that women more readily seek
medical care, and the awareness that women’s lives are particularly complicated by
chronic Lyme disease.
Finally, Johnson et al. found that “a substantial percentage of CLD patients
reported that their Lyme disease impaired their ability to work, resulting in either a
reduction in work hours, a modification of the type of work performed or quitting work
altogether” (p. 14). This study surfaced similar results regarding work limitations.

Literature on Women and Chronic Illness
In reporting on the literature about midlife women living with chronic illness,
Kralick (2002) observed that “when women are first confronted with a chronic illness
they appear to move through a complex trajectory that involves an ‘extraordinary’ phase
of turmoil and distress” (p. 146). Women are expected to be both caretaker and
breadwinner in modern society and adding health stressors to an already overworked and
overloaded woman can wreak havoc on her life. There are many aspects of women’s
lives that are affected when burdened with chronic sickness, including but are not limited
to finances, health insurance, family life, employment, education pursuits, and
relationships with family, friends, and co-workers. There is not one aspect of a woman’s
life that is not affected when she must deal with symptoms that rarely or never subside,
and which therefore affect her quality of life. Moreover, medical treatments, fear,

21

anxiety, and social dismissiveness or even denigration of the impact of a chronic
condition are burdens that, when added on to the daily stresses a woman faces, can make
life unmanageable and even unbearable.
As noted by Megari (2013), “The majority of chronic diseases hold the potential
to worsen the overall health of patients by limiting their capacity to live well, limit the
functional status, productivity and HRQoL and are a major contributor to health care
costs” (p. 142). In a study of women with breast cancer, Tiezzi et al. (2017) found that
“The diagnosis and treatment of breast cancer may negatively affect the physical and
emotional well-being of women because of adverse effects of treatment, fear of death,
and feelings of social devaluation” (p. 109). Similarly, Megari’s (2013) research on QoL
for patients with chronic disease found that “Women report lower psychological health, a
more negative perception on different aspects of their environment and a stronger
dissatisfaction with their finances and opportunities for recreation and acquiring new
skills” (p. 144). Yet the literature on HRQoL and chronic illness is still relatively limited,
as Shofany (2017) acknowledges: “We looked into selecting few of the great many
literature works regarding chronic patients’ HRQoL; the common hypotheses of
connection between quality of life, physical[,] mental and social factors and disease
symptoms; the HRQoL measurements as tools in the hands of various medical
researchers and into the particular connections between specific chronic diseases and
HRQoL. Yet many more chronic diseases remain poorly studied in this aspect” (p. 388).
This is certainly true for chronic Lyme disease.
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Summary of Current Studies
The above studies are all concerned with the impact of chronic illness on quality
of life, as summarized in Table 1.
Table 1: Literature on Chronic Illness and HRQoL Outcomes
Investigator(s)

Medical Condition

Adverse HRQoL Outcomes

Bayliss et al.

Chronic illness

Negative life impacts

Johnson et al.

Chronic Lyme disease

Significantly worse mental health
Significantly worse physical health

Kralick

Chronic illness

Turmoil
Distress

Megari

Chronic illness

Poor mental health
Poor physical health
Limited quality of life

Rangnekar et al.

Liver failure

Poor mental health
Poor physical health

Richardson et al.

Cancer

Unhealthy days
Loss of sleep
Pain

Tiezzi et al.

Breast cancer

Fear of death
Poor physical health
Poor mental health

Implications for Dissertation Research
We have solid data about the incidence of Lyme disease because the CDC tracks
its spread. However, extraordinarily few data are available about the impact of Lyme on
one’s quality of life, health care needs, and ability to work. At the time I initially decided
to conduct a survey of these impacts, I was not aware that the CDC had developed a
broad health-related quality of life metric that is used in numerous government
population studies and informs policy decisions, such as the goals for Healthy People
2020 (Office of Disease Prevention and Health Promotion, 2010). But the distinctiveness
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of the work by Johnson et al. (2014) makes clear how little literature exists about Lyme
and its impacts on HRQoL. There is even less written about women with chronic Lyme
disease and their quality of life, including the social and economic issues they face.
Addressing this gap and contributing to the body of knowledge about women with
chronic Lyme is part of what has inspired this dissertation research and the planned book
that will result.
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CHAPTER 3
RESEARCH DESIGN AND METHODS
Approach and Rationale
The study utilized a mixed methods approach across three phases of research:
quantitative (survey) research for Phase I and qualitative phenomenological (focus
groups) and narrative (stories) research for Phases II and III respectively. The
combination of these methods was well suited to an in-depth examination of women’s
lived socioeconomic experiences while coping with chronic Lyme and Lyme-like
diseases. According to Gall et al. (2007), “Many researchers believe that the methods of
qualitative research and quantitative research are complementary and that researchers
who use a combination in mixed methods research studies are in the best position to
create a meaningful picture of educational practices and problems” (p. 14). Each of these
research approaches—mixed methods, quantitative, and qualitative—and their relevance
to this work is discussed below.
In formulating this study, I was aware that the women who would opt to
participate were likely those whose lives have been most adversely affected by chronic
Lyme. I also anticipated that they would have a strong interest in being heard and
expressing their journey, especially in the context of research conducted from a respectful
stance. And indeed, especially as evident in the written narratives, the majority of them
have had horrible experiences. This dissertation describes some of their stories in the
context of scientific data. However, it is important to note that these are individual
experiences, not meant to be generalizable.
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Mixed Methods Research
Qualitative and quantitative methods can be mixed to improve the process of
researching difficult questions (Rossman & Wilson, 1994). Quantitative and qualitative
research methods each offer distinct insights into data and, when combined, can serve to
validate and reinforce each other. The combining of methods provides a more thorough
investigation. As described by Wisdom and Creswell (2013), “The term ‘mixed methods’
refers to an emergent strand of research that advances the systematic integration, or
‘mixing,’ of quantitative and qualitative data within a single investigation or sustained
program of inquiry” (p. 1). The research that forms the basis of this dissertation utilizes a
classic mixed methods design.
According to Locke et al. (2010), “The capacity of quantitative research to
describe, predict, and explain social and psychological phenomena has provided a
significant part of the foundation on which the modern social sciences has been erected”
(p. 91). It also is frequently the case that the academic community will consider
quantitative research to be more rigorous, giving the findings a greater degree of
legitimacy from a scientific methods standpoint. Any qualitative approach, on the other
hand, allows the researcher to reflect what is happening in dynamic relationships. It
allows for stories to be told and heard, giving voice to the participants. Quantitative
methods alone would not be able to explain fully the phenomena discussed in this
research, nor would it be fully reflective of the depth and breadth of the experiences of
women with chronic Lyme. At the same time, it is essential to have scientific data
complement the narrative findings. For this study, a mixed methods approach combines
the best of both worlds.
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Creswell (2014) describes mixed methods as having the potential to “develop a
stronger understanding of the research problem or questions” (p. 215). The strengths of
each are combined for a comprehensive analysis. He further describes a variety of mixed
methods styles, and the one that best suited my research is Embedded Mixed Methods (p.
221). The Phase I quantitative survey asked the questions and identified the issues; the
Phase II qualitative focus groups narrowed down and refined the topics; and the Phase III
qualitative personal narratives yielded the details and impact of the experiences. This
progression is described further in the Data Collection and Data Analysis Sequence
section of this chapter, below.

Quantitative Research
Approaches to Quantitative Research
Quantitative research applies models, theories, and hypotheses to the collection,
modeling, and analysis of typically numerical data via statistics. It has at its core
experimental and variable control or manipulation and the application of measurements
through developing instruments that investigate a hypothesis (Suter, 2011). Typically, the
results are investigated for generalizability across groups to understand distribution of a
given phenomenon across a population. According to Rossman & Rallis (2012),
randomization and standardization are what constitute generalizability. This study did not
“ensure that the experimental conditions were precisely the same” (p. 9). According to
Locke et al. (2010), “Validity and reliability are elusive qualities, and few studies are
designed in ways that resolve all possible threats to consistent truth” (p. 85). Therefore, it
is imperative to scrutinize these carefully.
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There are five distinctive styles of quantitative research:
1. Survey research—used for this study: The most widely used and basic form of
asking questions of respondents;
2. Descriptive research: Defines the people, the state of, or the phenomenon that is
being examined; does not answer the why, but rather it addresses the how, what,
when, and where questions of the problem under study;
3. Experimental research;
4. Correlational research; and
5. Causal-comparative research (Creswell, 1994; Ellis & Bochner, 2000; Gall et al.,
2007; Locke et al., 2010; Marshall & Rossman, 2015; Rossman & Rallis, 2016;
and Wisdom & Creswell, 2013).
Validity and Reliability
The mainstay when conducting any research is to examine validity and reliability
to ensure credibility. According to Locke et al. (2010), “Planning research requires many
decisions that ultimately will bear on the quality of the data collected and the credibility
of the findings” (p. 81). Validity addresses “truth telling” in research and is judged from
two vantage points, internal and external. Internal validity considers whether the
instrument is appropriate to the investigation in terms of collecting the data that can best
answer the question(s), and queries whether it meets the rigor of integrity. External
validity examines the issue of truthfulness in its application across populations and/or
situations (summarized from Locke, et al., 2010). In all research studies, questions of
validity and threats to integrity are possible, and it is vital to look at how any research
protocol addresses these.
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Reliability concerns consistency within the study instrument and in the method(s)
of collecting data. Often researchers will pre-test procedures to assess reliability, and I
adhered to this standard. In preparation for developing the formal survey, I had a series of
conversations with medical personnel, patients, friends, colleagues, and members of a
topic-related Facebook group and also conducted an informal survey to assess what
issues were most important to explore. Once the formal survey instrument was
developed, I conducted a pilot study to validate the method and make revisions, paying
particular attention to the details of consistency. Only after these steps were taken to
ensure reliability was the survey instrument finalized and broadly distributed. As Locke
et al. (2010) write, “Exceedingly careful attention to consistency of procedures across
people, contexts, and time; ongoing inspection of recorded data for evidence of
unexplained or unexpected content; and persistent effort to maintain high accuracy must
provide the support for claims about the reliability of what is captured in the data record”
(p. 85).
As a further test of validity and reliability, both the methods used for and the data
gathered through this survey were analyzed by two different teams of researchers and
statisticians at two different points in time (the second analysis was conducted four
months after the first). This allowed testing for consistency in the methods and findings,
and indeed the topics were consistent across both analyses. As described by Marshall and
Rossman (2006), the purpose of a survey is “to learn about the distribution of
characteristics, attitudes, or beliefs” (p. 125). These dual analyses confirmed that
quantitative survey research was the appropriate method to assure internal validity.
Additionally, using a survey allowed me to sample a specific population and then refine
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topics for further investigation from those data to make broader inferences and improve
understanding of the concerns (Locke et al., 2010, Marshall & Rossman, 2015).

Qualitative Research
Approaches to Qualitative Research
This study utilized qualitative research methods to learn about, understand, and
interpret participants’ experiences. As Marshall and Rossman (2006) observe, qualitative
research is “a broad approach to understand social phenomena” (p. 2). They describe
qualitative research as encompassing five major assumptions that align well with the
rationale for this study. Qualitative research:
1. Takes place in the natural world;
2. Draws on multiple methods that respect the humanity of the participants of the
study;
3. Focuses on context;
4. Is emergent and evolving rather than tightly prefigured; and
5. Is fundamentally interpretive (p. 3).
When studying a given population, one must consider the human component. Far
too often, in the name of science, people have been rendered into objects, thereby
trivializing the importance of the individual’s personhood and unique experiences.
According to Marshall and Rossman (2015), qualitative research is “pragmatic,
interpretive and grounded in the lived experiences of people”; researchers are “intrigued
by the complexity of social interactions expressed in daily life and by the meanings that
the participants themselves attribute to these interactions” (p. 2).
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Marshall and Rossman (2015), in writing about the variety of qualitative research
genres, state that “The various genres are naturalistic, interpretive, and increasing critical,
and they typically draw on multiple methods of inquiry” (p. 3). This study utilized two
different genres of qualitative inquiry: phenomenological (Phase II focus groups) and
narrative (Phase III narratives) genres.
The phenomenological genre of qualitative research is interpretive and
concentrates on the shared aims of a lived experience within a certain group of people, in
this case, women with chronic Lyme disease. The basic goal of this method is to describe
the landscape of the specific phenomenon (Wisdom & Creswell, 2013). According to
Locke et al. (2010), the interpretive form acts “as the primary instrument for data
collection [by which] the investigator builds an extensive collection of thick description”
(p. 184). In this phase of the research, I used focus groups to gather a host of detailed
information from women, elaborating upon the topics from the Phase I survey as well as
individual social and economic circumstances. The resulting “thick description”
constituted the data for an examination of the participants’ subjective experiences. “It is
out of these data that the elements and structure of the phenomenon can be identified as
described” (Locke et al., 2010, p. 187).
The narrative genre in qualitative research is also interpretive. It is a critical
method that allows humans to relate, decipher, and explain human interactions with a
personal level of understanding. Ellis and Bochner (2000) explain that the narrative form
allows for awareness in a way that expands our appreciation of people’s lives, with the
goal of understanding how individuals act and think as expressed through their accounts
of past and present circumstances. Personal narratives are a framework through which
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people observe, understand, and judge their own experiences. The reflective writing
process gives researchers a window into the nuances of their multiple experiences.
Newman (2000) succinctly states that “All research findings are someone’s
construction of reality…The point is to see the taken-for-granted with new eyes” (p. 3).
Likewise, Marshall and Rossman (2015) explain that qualitative researchers are
“exquisitely aware that they work in and through interpretations—their own and
others’—layered in complex hermeneutic circles” (p. 2). Narrative as a method has at its
roots a meaning that is detached from the moment of action; rather, it is a subsequent
analysis of that moment of action. In other words, narrative is a technique used to provide
an analysis of the details of an experience. As Gudmundsdottir (1998) put it, actions
“leave traces in the social space and become kind of artifacts of human activity through
collective memory” (p. 1). This dissertation research compiled, interpreted, and
deciphered these artifacts: the quantitative data from the survey (Phase I), the qualitative
data from focus groups (Phase II), and the qualitative data of women’s stories as
recounted in their own narratives (Phase III).
Validity and Generalizability
One of the critiques of narrative inquiry as a research method and the qualitative
data that result from it has to do with generalizability, i.e., whether the findings are
applicable on multiple levels and can be extended to larger societal questions. It is true
that qualitative data are often local, provisional, and personal (Gudmundsdottir, 1998).
Therefore, addressing external validity is all the more important. This dissertation took
these factors into account by utilizing both a survey to provide quantitative, empirical
evidence, and focus groups and narrative stories to provide secondary qualitative data,
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together constituting a robust, well-rounded study. In line with Creswell’s (2014)
notation on “qualitative generalization,” the purpose of this kind of investigation is “not
to generalize findings” (p. 203). This study is not meant to be broadly generalizable as it
is not known how many women have been impacted in these ways. In order to make this
study generalizable it would have had to be determined from the start to prove that all of
the findings would be “true” for the participants across all measures. Also, a larger and
randomized sample would have been needed, and the inquiry method would have been
standardized.
Goetz and LeCompte (1984) claim that “The credibility of research that is
contextual, theoretically eclectic, and comparative is threatened by and grounded in
factors different from those pertaining to experimentation and other forms of quantitative
research” (p. 222). Therefore, it is imperative that qualitative research be thoughtful,
truthful, and as accurate, including recognition of the researcher’s stance relative to the
research. That is the rationale for using personal stories submitted from life experiences.
Additionally, I was able to weave in portions of my own personal journey where relevant.
Newman (2000) declares that “The act of creating the narrative sets us up to be
detectives; the narrative offers clues to the kind of cultural values affecting our
judgements. Hence the need for critical incidents, for tracking the surprises in the daily
work we are doing” (p. 4). Identifying the “critical experiences”—”incidents” for
Newman, “artifacts” for Gudmundsdottir (1998)—that recur across the three data sources
is the crux of this research and is what provides validity.
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Data Collection and Data Analysis Sequence
As Wisdom and Creswell (2013) have noted, a mixed methods study uses
“procedures that implement qualitative and quantitative components either concurrently
or sequentially” (p. 1). The data collection procedure used for this dissertation research
was sequential: an important function of the survey was to provide a quantitative basis for
subsequent qualitative research. The survey enabled me to identify, investigate, and
confirm that these topics were predominant in the daily lives of the women under study.
Those topics also framed the research phases of focus groups and personal narratives that
followed. Figure 1 illustrates the data collection and data analysis sequence.
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Figure 1: Organizing Structure: Dissertation Research Sequence
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Planning Steps
As noted previously, the process of envisioning this study, evaluating its
feasibility, preparing the research questions, planning the methods, and beginning the
data collection began even before I was accepted into the doctoral program. Preacceptance, I took the following steps:
1. Posted several questions on the Women and Lyme Disease Facebook group to test
my hypothesis that conducting research on the socioeconomic impacts of Lyme
and Lyme-like diseases on women is important, and to identify what topics are
most central to their struggles with the disease;
2. Interviewed physicians, including general practitioners, Lyme specialists, and a
neurologist to generate content;
3. Met with colleagues to discuss the feasibility and worthiness of the study, and
formed a research team;
4. Formed an advisory panel;
5. Held preliminary, informal interviews with several Lyme patients to help inform
the questions and determine the topics;
6. Developed the study protocol and designed the survey based on the five identified
topics;
7. Submitted the protocol to the Institutional Review Board and received approval to
proceed;
8. Piloted the survey;
9. Refined the survey based on pilot results; and

36

10. Conducted the full survey, compiled the data, and had two independent analyses
of the results.
My work continued with the following steps post-acceptance into the doctoral program:
11. Decided how to further investigate and elaborate upon the five topics, based on
the survey results;
12. Submitted the second research protocol to the Institutional Review Board and
received approval to proceed with qualitative data collection;
13. Designed and conducted small focus group discussions, one for each research
topic;
14. Solicited narrative submissions; and
15. Analyzed, coded, compared, and contrasted the data and wrote the dissertation.

Deductive Research Methods
Creswell (2014) developed an Embedded Mixed Methods Diagram, illustrated in
Figure 2, which outlines the components of a mixed methods research approach (p. 221).
Table 2 then charts the steps taken in this dissertation research project, as guided by and
mapped onto Creswell’s concept.

Quantitative (or Qualitative)
Quantitative (or Qualitative)
Data Collection and Analysis (QUAN or
QUAL)

Interpretation

Qualitative (or Quantitative)
Data Collection and Analysis
(before, during, or after)(quan or qual)

Figure 2: Creswell’s (2014) Embedded Mixed Methods Diagram
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Table 2: Dissertation Research Sequence as Mapped onto Creswell’s (2014) Model
Creswell

Dissertation Research Sequence
* Preparatory steps and groundwork (discussions,
meetings, planning)

Quantitative Data
Collection

* Pilot survey, Women and Lyme Disease Facebook
Group (informal pilot survey via Facebook platform)
* Formal survey, Women and Lyme Disease Facebook
Group (formal survey via Qualtrics)

Quantitative Data
Analysis

* Analysis of survey
Second analysis of survey

Qualitative Data
Collection

Focus groups (5 topic-based groups and follow-up
discussion)

Qualitative Data
Analysis

Analysis of focus group findings

Qualitative Data
Collection

Narrative story submission

Qualitative Data
Analysis

Narrative story analysis and selection for relevancy

Interpretation

Analysis and weaving of findings
Limitations
Conclusions
Directions for future research

Note. “*” denotes steps taken prior to entering doctoral program.

Research Team and Advisory Panel
It was very important to work with a research team throughout the process of
designing and implementing the survey research, to ensure both the breadth of expertise
and the integrity of the research. In addition to myself (with my dual experience as a
researcher and a Lyme patient), the research design team included a university professor,
another Lyme patient, and a physician who serves Lyme patients. Subsequently, to help
analyze the survey data, we were joined by a research consultant with statistical
experience and a graduate student pursuing a PhD in statistics. A second round of data
analysis was conducted by a psychometrics PhD student who joined the research team
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shortly after data collection and the first round of analysis. Additionally, I created an
advisory panel for independent validation and fact-checking purposes over the course of
the study, including once the survey and focus group findings were compiled and the
narratives written.

Research Phases
Phase I: Survey
As noted previously, the survey portion of the research had already been
completed at the time I began my doctoral program: the research team and I designed,
piloted, and refined the survey instrument, obtained IRB approval, collected the data, and
analyzed the results. The survey research tool, including the informed consent
documentation and the survey itself (provided as Appendix D) was a “self-designed
instrument” (Creswell, 1994, p. 120), developed entirely by our team. The survey was
designed to elicit information with regard to the five pre-determined topics, i.e.,
diagnosis, relationships, medical struggles, work ability, and access to treatment. During
the design process, we reached out to the Research, Evaluation, and Measurement
Program at the University of Massachusetts Amherst to ensure that the questions and
structure would lend themselves to optimal statistical analysis. We also collaborated with
two medical professionals to review the survey items for appropriateness and relevance to
chronic Lyme disease and quality of life.
I secured permission from the administrators of the Women and Lyme Disease
Facebook group to survey the membership by discussing the intentions of the research
and sending them a proposal for review. The administrators did their own due diligence,
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gave permission, and indicated their confidence in the project as part of posting the
survey by noting specifically that we were the only researchers to ever be granted access
to the group for research purposes. This lent the work important credibility and
trustworthiness.
After designing the study instrument but prior to implementation, the advisory
panel was asked to review and comment on the survey questions. A pilot survey with 50
participants ensured the survey’s initial efficacy, reliability, and validity. In the pilot
phase, Locke et al.’s (2010) standards were relied upon to be certain that the instrument
was an appropriate and accurate tool in collecting the intended data, and that the resulting
data would be “a truthful reflection of what the study intended to examine” (p. 83). The
pilot study met these standards, and the full-scale implementation took place with only
minor adjustments to the formatting and content of the survey.
Inclusion criteria for survey participation were: being over the age of 18, being
female (the social media group that granted permission to survey its members was
exclusively a women’s group), residing in the United States (to avoid confounding
variables), and having direct experience as someone with Lyme or Lyme-like disease.
Responses were voluntary, and the respondents self-selected to participate. According to
Creswell (2014), a “nonprobability sample (or convenience sample), is one [in] which
respondents are chosen based on convenience and availability” (p. 158).
The survey instrument consisted of 91 questions and was administered using
Qualtrics, a program that conducts surveys and tabulates results electronically.
Participants were asked to provide demographic information and to assess to what extent
statements reflected their personal experience with Lyme in various aspects of their life,
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including their workplace, interpersonal relationships, and place of medical care.
Questions addressed income, economic status, health insurance resources, medical bills,
and financial coping strategies; educational status; health status, healthcare resources, and
experiences with the medical system and providers (including alternative medicine); and
social circumstances, including impacts on social and familial relationships and the
ability to work. Some questions had space for text entry responses; others had Likert
scale response options. Our target for participation in the survey was 500 responses, and
we closed the survey when we reached that number. After exclusionary factors and
eliminating those not meeting the study participation criteria, 373 survey responses were
utilized for analysis.

Phase II: Focus Groups
By the time the survey was concluded, I was enrolled in the doctoral program and
IRB approval for Phases II and III of my study had been obtained. The research modality
for Phase II was focus groups. The purpose of a focus group, according to Carey and
Asbury (2012), is to collect “rich detailed data” (p. 15). Onwuegbuzie et al. (2009)
observe that “focus groups are less threatening to many research participants” (p. 2).
Moreover, as Marshall and Rossman (2015) write, “One strength of focus group
interviews is that the method is socially oriented, studying participants in an atmosphere
more natural than artificial experimental circumstances and often more relaxed than a
one-to-one interview” (p. 154). In other words, focus groups are less intimidating than a
personal interview and more intimate than a questionnaire or survey. They are used for
gaining in-depth knowledge that is more difficult to access via other modalities. Having
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participants be at ease creates an atmosphere that is conducive to eliciting information:
group members share with each other, thereby prompting each other to remember or to
have additional opinions, and this generates data that would otherwise not be attainable.
As noted earlier, the rationale for the focus groups was to delve more deeply into
the five topics first explored in the survey, and thereby to investigate the topics more
intensely. Given the newness and uncharted waters of this research, beginning with topics
for review and analysis was most appropriate.
I conducted five focus groups, one each focused on diagnosis, relationships,
medical experiences, work ability, and access to treatment. Women involved with the
Lyme Resource Center in Northampton, Massachusetts, as well from a variety of
networks in the Lyme community were invited to be part of the conversation.
Unfortunately, due to the COVID-19 pandemic, the focus groups had to be conducted via
Zoom; however, this also proved beneficial in generating a larger pool, because the
women did not have to live locally to participate. The focus groups were limited in size to
between seven and ten women per session, in order to foster in-depth discussion.
At the beginning of each focus group meeting, the participating women were
asked two or three questions, which had already been provided by email prior to the
meeting as prompts from which to write about their experience(s), and also to draw a
timeline reflecting their narrative (see Appendix E for the focus group consent form and
questions). For example, “Please write about your work experience since being diagnosed
with Lyme. If you were supported in the workplace, or alternatively possibly stigmatized,
how did that occur?” Each woman decided on the main points from her personal
experience and summarized them in writing; these written responses were then submitted.
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The members of that focus group then jointly discussed the summaries and each other’s
perspectives. The discussions led to a further distillation of information regarding
additional items. This process served a two-fold purpose: first, the group collectively
learned information about each individual woman’s journey; and second, I gained
information from the group’s consensus about the topic under review. Conducting focus
group interviews was a critical element to corroborating and elaborating on the survey
findings, solidifying the topics, and creating a gateway into the narrative.

Phase III: Personal Narratives
In a separate but complimentary data-gathering effort, I asked women with Lyme
and Lyme-like diseases to submit stories about their experiences. Again, the five topics
provided crucial context; as Rossman and Rallis (2012) write, “searching for topics that
express meaning in participants’ lives” can frame such a study (p. 271).
To solicit personal narratives, I reached out to women in the Facebook group that
constituted the original survey population and to focus group participants. I also
contacted other Lyme groups, Lyme disease support centers, and personal acquaintances.
Each woman was invited to submit a one-page synopsis of her experience with Lyme,
which I then reviewed to determine alignment with the topics of the research. The most
compelling stories reflected the topics at hand, and I asked ten of the women to consider
writing a longer narrative for more detailed inclusion in the study, to be submitted
anonymously through the research website (www.bittenbylyme.com). I provided prompts
to help guide their writing, with questions such as: How has your illness affected your
relationships? How and with whom do you share information about your illness and/or

43

medical struggles? How has your illness affected your ability to work? How has your
financial status affected your ability to receive treatment? What have been your greatest
challenges? See Appendix F for the narrative consent form and prompts.

Procedures for Data Analyses
Analyzing the Quantitative Data
The data gathered through the survey were analyzed by two different teams of
researchers and statisticians at two different points in time (the second occurring four
months after the first). This allowed testing for consistency in the findings; as noted
earlier, the topics were consistent across both analyses. Additionally, the data were
analyzed using different methods. The statistical procedures used for this survey included
crosstabulations, chi-square tests for significance, t-tests, and one-way analysis of
variance (ANOVA):
•

Crosstabulation is a descriptive analysis of how respondents’ answer selections
overlap between items (e.g., how many respondents who used a specialized doctor
reported trusting the healthcare system overall?).

•

Chi-square tests are used to determine statistical significance. In the social
sciences, a chi-square equal to or less than 0.05 is considered statistically
significant. In our analysis, chi-square tests were used to report the likelihood that
the findings as reported in crosstabulations were not merely due to chance.

•

T-tests analyze data for differences in means between two groups based on one
attribute of interest, such as age. A statistically significant t-test for our data
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indicated that, on average, there were differences between groups that were not
likely due to chance.
•

One-way ANOVA evaluates the differences in the means of more than two
groups based on one attribute of interest, such as age. In this case, a one-way
ANOVA was used to evaluate the mean differences between three income level
groups. A statistically significant one-way ANOVA indicated that, on average,
differences between the groups were not due to chance.

Analyzing the Qualitative Data
As discussed earlier in this dissertation, both the WHO (2012) and the CDC
(2018b) have offered definitions of quality of life. I used these definitions as guidance to
shape the topics under investigation in this research:
•

Social relationships: Sense of belonging, participation in activities, love, family,
friendships.

•

Emotional well-being: Self-worth, psychological stability, self-esteem.

•

Quality of environment: Sense of belonging, general safety to move about, safe
home environment.

•

Personal safety: Life of structure, ability to move freely, not living in fear.

•

Belonging: Inner contentment, love of life and self, spirituality.

•

Financial and material well-being: Affording life, living comfortably, basic needs
met (food, clothing, water, shelter).
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•

Work: Meaningful activity, self-worth, productive member of society, affordable
lifestyle, health insurance.

•

Health: Body functioning and integrity, physical comfort, affordable health care.

I aligned quotes and excerpts from both the focus group sessions and the narrative reports
with these categories, and then identified, coded, summarized, and classified the Quality
of Life aspects accordingly.

Summary of Research Design
As described in the preceding discussion of research design and methods, this
study is comprised of quantitative and qualitative data, in the form of statistically
analyzed survey findings, detailed supplemental information from focus groups, and
anecdotal evidence derived from personal narratives. This mixed methods approach
provides a nuanced perspective on the problem under study and tells specifically how the
study population of women with Lyme who participated in this research are affected by
their disease and the challenges they face.
This research also includes my personal experiences and perspective. According
to Megari (2013), “QoL is inherently a dynamic, multilevel and complex concept,
reflecting objective, subjective, macro-societal and micro-individual, positive and
negative influences which interact” (p. 14). I know very well from my own experience of
chronic Lyme disease, with the overlay of an unnecessarily complex and at times
inaccessible and unaffordable healthcare system, how significantly one’s physical,
psychological, and social functioning can be affected. It is important that those with
chronic illness be able to navigate life with as little interruption and disappointment as
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possible, in order to enjoy the best possible quality of life. The mixed methods research
approach provides a fruitful avenue for documenting the complexities, corroborating
findings across the research phases and investigating the nuances of these experiences.

47

CHAPTER 4
FINDINGS AND ANALYSIS
The three-phase, mixed methods model used in this dissertation provided a
multifaceted framework to put forward the research hypothesis—that chronic Lyme
disease adversely affects the quality of life of women who have it—and then to identify,
refine, investigate, and analyze the corresponding research questions and topics. In this
chapter, evidence collected during all three research phases is presented. To begin, data
gathered in Phase I by means of the scientific survey instrument are reviewed; these data
provide quantitative support for the qualitative findings that follow. Next, Phase II
findings are presented according to the five focus group topics. Then, Phase III narrative
data highlight women’s individual stories and voices.
First, though, at the heart of this dissertation research is appreciating the stories of
individual women who have experienced the socioeconomic impacts of Lyme and Lymelike diseases. Therefore, we begin with brief biographies of some of the participants who
suffer from Lyme, together representing a robust sample of study participants across the
three research phases. 3 Pseudonyms have been used to protect their confidentiality.

Study Participant Biographical Sketches
Alice: Alice worked for one of the largest pharmaceutical companies in the world,
with a good salary and excellent healthcare coverage. Her Lyme journey began seven

3

Phase I of the research protocol collected survey responses anonymously; however,
each of the women profiled here indicated that they had completed the survey, in addition
to participating in Phase II and/or Phase III.
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years prior to diagnosis and involved dozens of medical doctor visits. Due to illness she
stopped working permanently in February 2018, and also had to halt her pursuit of a PhD.
She has been all but bankrupted by the disease, with little to no income at this time. Her
social life and daily living have been altered greatly: she feels accomplished if she can be
outside the home one day a month to run errands. Alice has become estranged from many
of her friends and family, who do not understand her struggles with Lyme. Due to her
illness and resulting changes in finances she has been forced her to live with her mother;
however, her mother is a hoarder and the filthy environment triggers Alice’s symptoms.
Alice, like many others, has suffered trauma as a result of her challenging journey.
Gloria: Gloria, a 62-year-old married woman with two adult children, has been
sick for four years. She has a master’s degree and is professionally accomplished, but had
to leave her teaching job due to her illness. She has consulted with more than nine
infectious disease doctors and tried five different alternative pathways to healing, but all
attempts at wellness to date have been futile. Previously a very social person, she is now
housebound, and she and her husband no longer have quality time together. Her disease
has greatly affected her quality of life.
June: June believes that she was born with Lyme disease: she had many illnesses
as a child, and her brother and mother were also frequently sick. Her childhood as well as
her adulthood have been characterized by illness and misdiagnosis. She was married at
age 18 and had four children, but after almost two decades of constant ill health, her
marriage fell apart. After ten misdiagnoses, in 2011 she tested positive for Lyme and coinfections. Her illness has become even more unmanageable over time. She had some
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financial security due to a sizeable inheritance left her by her parents, but that resource
has been depleted.
Kiley: Kiley is a 46-year-old mother of three boys. She is well-educated, with a
college degree, and comes from a middle-class background. She resides in southwestern
Pennsylvania but grew up in Long Island, close to Lyme, Connecticut, the disease
epicenter. Kiley remembers a childhood full of illness. She was bitten at age 14 and the
tick was discovered during an appointment with an ENT doctor. She was treated with an
antibiotic for two weeks prophylactically. The prophylaxis did not work, however, and
eventually she became bedridden. The following years brought many doctor and
specialist visits, to no avail. In 2006 she was diagnosed and treated with a hybrid
approach (pharmaceuticals and alternative therapies) with a degree of success, but in
2014, with the birth of a child, had a major setback and began another grueling journey of
testing and treatment.
Leslie: Leslie remembers a tick bite in 1983, but she was not diagnosed until
2002; during the intervening 19 years she was misdiagnosed by multiple doctors,
including at prestigious medical facilities such as the Lahey Clinic in Boston. As a
software engineer, Leslie had reasonable financial security, but she lost the ability to do
her job and her social life deteriorated. She has two sons, one of whom also contracted
Lyme; it was then that she finally got her own diagnosis. Her marriage failed as a result
of her sickness and her sons abandoned her. In her forties, Leslie ended up moving in
with a friend to aid her recovery.
Rose: Rose is 67, lives in the Midwest, and is very active in Lyme advocacy
arenas. She was an award-winning full-time schoolteacher and was pursuing an EdD
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degree when she began to be plagued by Lyme and five co-infections. That was the
beginning of an arduous journey during which Rose saw more than 30 doctors but was
continuously denied testing for Lyme, despite her repeated requests. Instead, she was told
she possibly had psychiatric issues. She had been divorced three years earlier and had
sole custody of four children: two teenagers, a middle schooler, and an elementary school
student. She knew her problems were physical, but her children all began to think she
was crazy. Within six years she was totally disabled and had to leave her job and
academic program. Rose eventually flew to the east coast to get tested for Lyme,
resulting in a confirmation of her suspicions. Her treatment journey has been endless. She
had built a healthy retirement account but was bankrupted by her disease. She now
receives federal disability as well as disability from her former employer. Before being
diagnosed, Rose had been prescribed a benzodiazepine for insomnia; after a two-year
taper, she is now in active withdrawal. She has been diagnosed with complex PTSD,
battles both physical and emotional trauma on a daily basis, and lives a very limited life.
Even so, Rose has managed to create meaning from her struggles and is now a popular
and successful advocate in charge of a huge Lyme advocacy group.
Sabrina: Sabrina is a young, married, well-educated professional with an
advanced graduate degree. She is in her mid-thirties, has no children, and works as a high
school librarian in the Washington, DC area. In hindsight, Sabrina believes she was most
likely bitten on July 25, 2020, when, for the first time during the COVID pandemic, she
left the house for an outing, to hike a trail in Maryland. She and her wife took all the
recommended precautions and did a “tick check” when they returned home, and both
believed they were clear. However, Sabrina has very curly long hair and it would be
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difficult to find a tick in it. A few days after the hike, she developed flu-like symptoms
that lasted several days. By August, her once infrequent migraines began to occur on a
daily basis, complicated by an already present seizure disorder. Over the following ten
months Sabrina saw multiple doctors, including her PCP, an endocrinologist, a
neurologist, an immunologist, a Lyme-literate doctor (LLD), 4 and many more. As she
observed, “Before my experience, this is what I knew about Lyme: A tick bites you; you
get a bull’s eye rash, treat with antibiotics for a couple of weeks, then fully recover. Now
I understand how wrong I was.”

Phase I Research Findings
The first method used in this study was quantitative, taking the form of an
anonymous survey distributed broadly through a Facebook group, with the goal of
exploring the socioeconomic impacts of Lyme disease on women. The literature review
in Chapter 2 discusses two quality of life studies (Johnson et al., 2014; Megari, 2013),
both of which focused on the health implications of chronic disease. Likewise, the CDC’s
(2018a) Health Related Quality of Life metric explicitly focuses on health implications
and impacts on quality of life. In this dissertation, quality of life is considered more
broadly, and as such is informed by but does not rely on the CDC’s metric. Rather, the
survey questions were designed to elicit data about respondents’ experiences with the
health care industry (including alternative medical practitioners) vis-à-vis their Lyme

4

There are three categories of doctors who specialize in Lyme treatment: Lyme-literate
medical doctors (LLMD), Lyme-literate naturopathic doctors (LLND), and Lyme-literate
doctors (LLD).
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diagnosis and chronic Lyme’s impacts on their social and familial relationships, financial
circumstances, and ability to work and work relationships.

Review of Findings
The goal for data collection for Phase I was 500 responses, and the survey was
closed at that number. After excluding surveys that did not meet the study’s criteria, 373
responses were analyzed. Demographically, the population of eligible respondents was
predominantly white women (95.9%), with the majority in partnered relationships
(73.2%); they ranged in age from 19 to 80 years. The survey questions were clustered in a
manner that, during data analysis, sorted participants into those indicating they had either
(a) “fewer and less severe” symptoms or (b) “more and more severe” symptoms. This
sorting allowed for nuanced correlations between the variables associated with each
cluster.
Below is a summary of the survey results for each of the five topic areas.
Road to Diagnosis
•

96% do not trust the medical industry to diagnose Lyme and Lyme-like diseases.

•

72% were medically diagnosed after multiple misdiagnosis.

•

71% believe that primary care doctors are not knowledgeable about Lyme and
LLDs.

•

54% believe Lyme tests are ineffective and inaccurate.

•

23% were diagnosed with one test.
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Relationships and Support
•

83% reported they educate friends and family about the disease.

•

68% tell friends and family about their health issues.

•

67% do not go to others for help.

•

62% believe they are seen and treated differently by friends and family.

•

60% reported that friends, family, and others have pulled away regarding their
disease.

•

59% reported being able to rely on friends and family to help with
treatment/doctor visits.

•

58% reported willingness to share their disease with others they know.

•

57% indicated that friends and family do not understand the impact of their
disease.

•

55% reported they share treatment decisions with friends and family.

•

53% feel stigmatized by friends and family regarding the disease.

•

51% reported willingness to share with new people in their life.

•

32% reported willingness to share with new romantic partners.

•

27% reported they share the experience of the disease with significant others.

Medical Struggles
•

98% believe that specialized doctors know more treatment options.

•

89.5% do not trust the medical industry.

•

86% believe that primary care doctors do not know numerous treatment options.

•

85% who saw a specialized doctor trusted the specialized doctor.

•

72% sought alternative and specialized doctors for treatment.
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•

60% have trust in alternative treatments.

•

56% of those who saw a specialized doctor believe the specialized doctor was
knowledgeable about Lyme and LLDs.

•

44% chose a specialized doctor due to lack of trust in a primary care doctor.

•

36% sought alternative treatment due to dismissive doctors elsewhere.

•

12% have trust in traditional treatments.

•

2% believe that Lyme and LLDs are taken seriously by the medical industry.

Work Ability
•

75% indicated the disease interferes with the ability to do their job.

•

62% reported having to take additional time off for their disease.

Access to Treatment
•

80% believe that medical bills are not affordable for treatments.

•

68% believe that specialized doctors are more accessible.

•

56% of those seeing a specialized doctor did not believe it was affordable.

•

54% did not see a specialist due to affordability.

•

42% of treatments at the time of survey were covered by insurance (for those who
had insurance).

•

32% of treatments at the time of survey were not covered by insurance (for those
who had insurance).

•

22% reported half of expenses were covered by insurance.

•

22% did not see a specialist due to accessibility.
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Key Points
The psychometrician who performed the second set of data analyses on the survey
results prepared a report of preliminary findings (included as Appendix G). Key points
are excerpted and summarized below.
Financial and Educational Findings
Income was significantly different between symptom groups (Fewer and Less,
More and More). Those with fewer and less severe symptoms reported large
household incomes (mostly at or above $100,000), while those with more and
more severe symptoms reported household incomes at or below $29,999. As one
might expect, those with higher income tend to have reported a higher education
level. These results could be a result of higher education levels leading to higher
income levels; however, one could also wonder if Lyme has impacted people both
financially and educationally (i.e., because of Lyme, persons are unable to
continue their education and as a result earn a lower income). If there were an
increased awareness from providers and community (the latter category) would
have a better chance at being treated properly. If someone has access to or makes
more money, they can pay out of pocket for care. Therefore, those with less
money do not have as equal access to treatment.
Health care Findings
•

There is no statistically significant difference between respondents with
fewer and less severe symptoms and those with more and more severe
symptoms in terms of accessing specialized medical care.

•

Trust in a primary care provider does not have a significant impact on
whether an individual will seek out a specialist. Further research is needed
to explore this preliminary finding;.

•

Lack of access to and affordability are the reasons why respondents do not
seek out specialized medical care. These are more important than trust in
the primary care provider.
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Social and Family Relationship Findings
•

There is a statistically significant difference, across all items, between those
with fewer and less severe symptoms and those with more and more severe
symptoms.

•

In terms of social assessments, those with more and more severe symptoms
report more negative social experiences. This is not statistically significant.

•

Expanding on this notion is that those with fewer and less severe symptoms
report more support from their social networks than do those with more and
more severe symptoms.

Workplace Findings
•

Across many items, those with fewer and less severe symptoms report
greater satisfaction with their employers’ ability to accommodate needs
related to and sympathize with their disease.

•

Those with more and more severe symptoms report greater difficulty
adapting to the workplace.

Phase II Research Findings
The qualitative research for this dissertation began with Phase II and took the
form of a series of topic-based focus group sessions designed to elicit more specific and
individualized reflections on the core research topics. They were invaluable for verifying
that the topics identified and queried in the survey were in fact relevant to and
representative of the issues facing the target population. As noted by Wolff et al. (1991),
“In conjunction with a survey, focus groups can be used to illustrate or confirm survey
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results, elaborate or clarify survey findings, or to suggest new explanatory categories not
captured by the survey or unanticipated in the original research design” (section:
Abstract). In focus group research, participants are “selected because they share certain
characteristics” and can together “generate new understandings” (Rossman & Rallis,
2012, pp. 188-189); the participants in this study’s focus groups all share the chronic
illness of Lyme disease, are members of a Lyme social media group, are women, and
have had their lives altered drastically as a result of their disease.

Focus Group Structure and Composition
All focus group data were collected between March 12 and March 31, 2021. It is
important to note that the focus groups took place during the COVID-19 pandemic,
which meant that in-person meetings were seriously curtailed. This required the
researcher to be creative, and the groups were therefore conducted via Zoom, a secure,
reliable video platform used for a variety of communications, including meetings,
individual and group chats, webinars, and online events.
Eleven women participated in the focus groups. Prior to the commencement of the
focus groups, participants were sent a description of the study and a request for their
signature of informed consent, indicating their understanding of and willingness to
participate in the research. As part of the consent, participants were asked whether they
were willing to be recorded. If not, their responses were solicited in written form instead.
For purposes of confidentiality the recordings were accessible only to the researcher and
protected by a secure password. The transcriptions of the recordings were likewise
protected. Additionally, each individual’s responses were de-identified and coded with a
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letter (A-K). At the beginning of each focus group meeting, the investigator again
reviewed what the meetings entailed, the expectations of participation and confidentiality,
and also requested verbal confirmation of consent.
The five focus groups were aligned with the five topics explored in the survey
regarding the effects of chronic Lyme and its associated diseases on quality of life. All
eleven participants were invited to be part of all five groups; the average number of
participants per group was 7.8. Their distribution within the groups was as follows:
•

Focus Group 1—Road to Diagnosis: 9 participants (A, B, C, D, E, F, H, I, K), 6
via Zoom and 3 via written comments.

•

Focus Group 2—Relationships and Support: 7 participants (A, B, C, D, F, I, K), 5
via Zoom and 2 via written comments.

•

Focus Group 3—Medical Struggles: 6 participants (A, C, F, H, I, K), 4 via Zoom
and 2 via written comments.

•

Focus Group 4—Work Ability: 7 participants (A, C, E, G, H, I, K), 4 via Zoom
and 3 via written comments.

•

Focus Group 5—Access to Treatment: 10 participants (A, C, D, E, F, G, H, I, J,
K), 7 via Zoom and 3 via written comments.
The focus group meetings were scheduled to last 90 minutes; however,

participants stayed up to two hours as the discussions were energetic. They praised the
research and felt it was a much-needed investigation. As one said, “This is exceptional
research Dale, and we need to be heard” (participant J). Two weeks after the last focus
group meeting, participants were invited to attend a two-hour post-focus group
discussion, which was again held via Zoom. The purpose was to summarize the
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discussions, check topic appropriateness, and solicit participants’ feedback on the
process. The responses were overwhelmingly positive.

Review of Findings
Each of the following sections includes the focus group prompts, a chart of the
results (Figures 3-7), and a discussion of what the topic revealed.
Focus Group 1—Road to Diagnosis
The nine participants in Focus Group 1 were asked to respond, to the best of their
recollection, to the following prompts:
•

How long did it take to get diagnosed and why?

•

Provide a timeline of your medical journey pre-diagnosis. Please list the dates,
times, and symptoms you sought treatment for. What other diagnoses were you
given?

•

Provide a timeline post-diagnosis. Please list the dates, times, appointments, and
symptoms you sought treatment for.
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Focus Group 1 Results
Spent more than 7 years to gain diagnosis.

8

Had multiple systemic infections with multiple
chronic symptoms.

9

Were dismissed or refused treatment by
doctors.

6

Had visited multiple doctors.

8

Had a traumatic injury or stressor prior to
Lyme explosion.

5

Remember tick bite.

7

Have seen 2 or more medical specialists.

9

Note. For the fifth finding, regarding whether one had a traumatic injury or stressor prior to
Lyme explosion, it is possible that more than the five respondents had this experience but
did not mention it, since this was not posed as a direct question in the focus group meeting.

Figure 3: Analysis of Findings: Road to Diagnosis
Focus Group 1 elicited the highest number of issues regarding quality of life for
women with Lyme disease. The findings included their experience of lengthy and
arduous journeys to obtain a diagnosis, which involved seeing many different doctors and
specialists. Despite having multiple diseases or infections occurring simultaneously, they
were dismissed repeatedly by all types of medical professionals. For example: “The
Infectious Disease doctor was dismissive and the worst doctor’s appointment I have ever
had and offered no solutions or treatment” (participant K).
Most women recalled a tick bite: “I remember being bitten multiple times and
only one time going to see a doctor and was prescribed antibiotics prophylactically”
(participant J). “I remember being bitten in Florida while on vacation” (participant G).
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These anecdotes are consistent with the survey, where most respondents recalled a tick
bite.
Focus Group 1 findings confirm the research hypothesis that the road to diagnosis
is a relevant and indeed major factor in assessing and influencing the quality of life for
women with chronic Lyme disease.
Focus Group 2—Relationships and Support
The seven participants in Focus Group 2 were asked to respond, to the best of
their recollection, to the following:
•

How has your illness affected your relationships (any and all)?

•

Describe your primary relationship(s) and how they may have changed after
diagnosis.

•

•

What kind of support were you able to access?
•

Financial

•

Emotional (therapy)

•

Logistical

•

Physical

•

Spiritual

•

Other

Where did that support come from?
•

Friends

•

Family

•

Church

•

Therapists
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•

Workplace

•

Professionals

•

Other
Focus Group 2 Results

Relationships (all styles) changed for the
worse (most ended).

7

Romantic relationships ended or not able
to have.

5

Distanced from primary relationships
(family, friends, children, partner).

6

Support found in alternative health
treatments/approaches and LLMDs.

7

Insurance does not cover the needed
treatments, exhausted all financial…

7

Practice meditation and other stress
reducing activities.

7

Figure 4: Analysis of Findings: Relationships and Support
The women in Focus Group 2 expressed that the changes in their relationships
were severe. The romantic nature of the relationships changed in more than half of the
women’s lives, while other participants did not engage in romantic relationships while ill.
“I lost everything including my family, kids, and husband and had to leave graduate
school; they all thought I was nuts” (participant G). The women in this group conveyed
that the people most important to them pulled away emotionally and/or physically and
had limited understanding and tolerance for their disease.
Another major impact was that the women found alternative treatments and
stress-reducing activities to be beneficial but expensive. “I cannot afford alternative
treatments, even though I know they are beneficial, [because] I lost my job” (participant
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A). Moreover, traditional insurance was found to not cover the needed and/or preferred
treatments.
These Focus Group 2 findings indicate that relationship changes and lack of
support in key relationships are major factors affecting the quality of life of women who
have chronic Lyme disease.
Focus Group 3—Medical Struggles
The six participants in Focus Group 3 were asked to describe in detail their
experiences with the following:
•

Doctors, including specialists

•

Diagnosis by said doctors

•

Treatment successes or challenges

•

Alternative methods and treatments sought
Focus Group 3 Results

Specialist were seen in excess of 5 or more
types and multiple visits. (endo, ortho, cardio,
neuro, psycho hematologist, dentist,
infectious disease, acupuncture,
homeopathic, naturopathic, etc.)

6

Successes were minimal including coming off
pharmaceuticals, and alternative protocols
working. Flares off and on. These are seen
as successes when you are so ill that a tiny
improvement is seen as a victory.

6

Figure 5: Analysis of Findings: Medical Struggles
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This focus group revealed that, for all participants, medical struggles had a
significant and adverse impact on their quality of life. All the women reported seeing in
excess of five specialists over multiple visits, and they experienced minimal success with
a variety of treatments. As one remarked, “I saw more than ten doctors, an
endocrinologist, a cardiologist, and more in one week, but no one knew what was wrong
with me” (participant A). Most women were comfortable seeking alternative or wholistic
therapies but could not afford the prohibitive costs of the extended treatments, and this
adversely affected the efficacy of the treatments. “I just could not see my specialist as
much as I needed as it was too expensive” (participant E). They added that it was
worthwhile to see specialists, even when the success was undermined due to infrequent
visits, and wished that these treatments were covered by insurance or were otherwise
more affordable.
The experiences of women in Focus Group 3 confirm that quality of life for
women with chronic Lyme disease is significantly affected by medical care and
resources.
Focus Group 4—Work Ability
The seven participants in Focus Group 4 were asked to describe in detail their
experiences with the following:
•

Describe your working ability pre-diagnosis and post-diagnosis. How did/does
Lyme affect your ability to work?

•

Have you had to change careers or leave your job?
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Focus Group 4 Results

Diminished capacity for work.

7

Multiple symptoms made work difficult to
impossible.

6

Asked for legal "reasonable
accommodations," lack of support.

5

Reduced hours and/or left job.

7

Figure 6: Analysis of Findings: Work Ability
These results demonstrate that chronic Lyme significantly affects one’s ability to
work, and that work supports are significantly altered and/or absent. The number of
women asking for accommodations in this focus group was 71%; however, all had a
diminished capacity to work.
Participants also experienced illnesses and a decline in cognitive abilities that
prevented them from working. In fact, 100% of women left or altered their employment
situations. “My cognitive decline led to my leaving my job. I just could not do my job. I
was great at my job before this random illness” (participant G). Another woman
remarked: “I had no choice but to leave my job; I could not think nor function”
(participant C).
Focus Group 4 results confirm the survey findings that one’s ability to work is
severely impaired by chronic Lyme.
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Focus Group 5—Access to Treatment
The ten participants in Focus Group 5 were asked to recount to the best of their
recollection, the impact of the following.
•

Has your health insurance or lack of health insurance hindered your ability to get
treatment? If so, how?

•

Has your overall financial status affected your ability to receive treatment? If so,
how?
Focus Group 5 Results

No insurance or lack of insurance when had
to leave job due to illness.

10

Mainstream doctor visits mostly covered
and coverage often exhausted.

10

Exhausted most to all personal savings,
retirement, and or liquidated assets.

6

Limited treatment due to lack of coverage.

8

Wholistic (eating well) and alternative
treatments are expensive.

7

Figure 7: Analysis of Findings: Access to Treatment
The findings from Focus Group 5 indicate that adequate insurance coverage and
access to financial assets are critical to receiving (quality) care. For participants who had
to leave a job, the lack of insurance caused disruption in treatment. Moreover, while most
mainstream treatments are covered by health insurance, the responses given across all
focus groups indicate that mainstream treatments are often not effective, nor do general
practitioners understand or have the capacity to treat chronic Lyme/LLDs. “I saw many
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different doctors that took my insurance, but they did not know what was going on with
my health. Then I found an LLD, and she was great but did not take insurance”
(participant F).
In confirmation of the survey hypothesis, these findings demonstrate that
treatment options are limited due to insurance issues, and alternative treatments—
including healthy food choices—are expensive.

Summary
Collectively, the five focus groups did exactly what was intended: they dispelled
any inaccuracies in the direction of the research, confirmed and validated the initial
survey findings, and supported and deepened the data. Most important, the five topics
that shaped the focus groups proved to be overwhelmingly accurate. In fact, the findings
were more significant than expected, likely because these gatherings provided a
conducive setting in which the participants could elaborate on their experiences in detail
with a trusted group of like-minded women, provide considered information about the
treatment and issues they face and have faced, and also contribute to the larger narrative.
The post-focus group meeting was devoted to a follow up discussion about the
process and served as a validation strategy. Here I employed “member checking” as
defined by Creswell (2014, p. 201), where the participants provided assurance that the
topics were accurate and applicable to their experiences.

Phase III Research Findings
Phase III of this dissertation research involved soliciting narratives in which
individual study participants were asked to describe their personal journey navigating
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Lyme disease, thereby leading to a more comprehensive and contextualized story
collection and story-telling process. A total of 22 women contributed narratives. Some,
but not all, were provided by focus group participants; the additional accounts served to
provide fuller validation and greater nuance. As with earlier data collection, the Phase III
narratives were assigned and coded in alignment with the five research topics. The
excerpts below capture each woman’s experience in her own words; pseudonyms are
used to protect confidentiality.
Narratives
Road to Diagnosis
Alice: “No one believed me because Lyme is not a serious disease and has no
serious complications. In reality, the complications are severe, the list of intense
symptoms run long, and we are being completely ignored by society.” “I got different
answers constantly from different doctors.” “No doctor listens to the words I have to
say.” “No doctor cares whatsoever that I am bedridden 70% or more of the time and have
been going continuously downhill for the last few years.” “No doctor cares that I am a
very levelheaded and intelligent adult who is self-aware, analytical and logical.” “The
only doctors that care about whether I live or die from the illness that is occurring in my
body are Lyme Literate Medical Doctors.”
Gloria: “My nightmare began six years ago.” “Doctors have dismissed me even
after seeing the Western Blot [diagnostic test results]. They say that I do not have the
right symptoms, or else it is anxiety.” “All attempts at wellness or even a little better
health have been futile.”
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June: “The doctor was consulted but he told my mother I was just pretending so I
would not have to go to school.” “[I] spent 17 years attempting to get a diagnosis and was
misdiagnosed at least 10 times.” “[I was very sick one night and] it was very scary and I
took myself to the Emergency Room the next morning, even here tests came back
negative.”
Kiley: “[The doctor] told me there is no such thing as Lyme disease that was not
cured with a two week course of antibiotics, and that I had a virus I would get over.” “A
doctor examined me and said, I see really sick people and you are not one of them and to
stop being untruthful.” “Western Blot [tests] kept coming back negative—hence docs
said it could not be Lyme. In desperation my parents took me to top doctors in New York
and the Northeast trying to find out what was wrong with me.”
Leslie: “Lyme wasn’t even a thought while parading back and forth to my
primary care practice for infection after infection. I had CAT scans on my sinuses, scans
for my heart (it was hurting like a muscle ache all the time) and many vials of blood for
attempts at diagnosing what I was dealing with at that time.” “[I had] run out of steam,
feeling hopeless and defeated.” “[Even after diagnosis,] my primary care doctor still did
not want to confirm I had Lyme.”
Marnie: “I went to the doctor’s office countless times for various illnesses over
the span of my lifetime, no doctor ever looked at the whole picture, just band aids.” “I
just thought this is how it is, everyone has extreme fear and anxiety, how would I know
any different as a child?” “I really did not know anything about Lyme being serious back
then, I was cavalier about it, I did not know better.”
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Rose: “I begged 30 doctors to test me for Lyme disease.” “Again, like many
others I was denied and told I was anxious, depressed, or perhaps bipolar.” “[Being
diagnosed] was my first glimmer of hope.”
Sabrina: “All of my symptoms intensified making it nearly impossible to
function and perform daily activities.” “The joint and muscle pain left me feeling
crippled—I no longer felt like a woman in her thirties, but more like a woman in her
eighties.” “[One doctor said] that my Western Blot was negative therefore I did not have
Lyme disease.” “I cried with relief to finally have answers. But also felt completely
overwhelmed with the results. I knew I was sick but did not realize how sick I had
become.”
Summary: Quality of life impacts of despair and hopelessness in the long pursuit
of a diagnosis are visible throughout these participant narratives. It is assumed with most
illnesses, in the Western medical model, that if you can get a diagnosis, especially early
on, then you can be treated and have reason to hope for some relief. Being diagnosed
with chronic Lyme is an entirely different experience. Many of these women were
gaslighted by the medical industry, and/or their symptoms were trivialized, and/or they
were told they likely had a psychiatric condition or were hypochondriacs. They suffered
acutely and needlessly for long periods of time in the effort to secure a diagnosis and
move forward with appropriate treatment. Unsurprisingly, this can cause a defeatist
attitude, which for some has led to depression. The road to diagnosis for chronic Lyme
disease has nearly destroyed many a life. Participants’ mental health, finances,
relationships, and overall well-being have withered away. The impact on quality of life is
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devastating: years and years spent sick, unable to perform daily life, with no definitive
diagnosis, while being disbelieved and undermined throughout.
Relationships and Support
Alice: “Due to being ostracized by society, due to lack of quality information
about this disease, I am completely unable to share about my health with my family and
friends.” “[When meeting new people] if I mention I have Lyme disease, I immediately
receive a smirk and a head shake.” “No one believes this is a serious life threatening
disease, no one takes it seriously.” “I couldn’t really have a social life, I couldn’t really
date, because I was so sick and in so much pain.” “This illness drastically changed all of
my relationships in my life. Not one relationship wasn’t affected for the worse.”
Gloria: “I am so sick of being sick, I spend most of my time in my room so as not
to burden anyone.” “I cannot socialize with my friends or even take a walk without
feeling terrible pain.” “Friends don’t want to hear about my being sick.” “At 64,
everything just seems impossible.” “[I have a] wonderful husband who married me
despite my being sick.”
June: “I no longer played outside, school had become a living nightmare.” “Life
is very different for me now. Lyme disease has shaped my life for its entirety it seems.”
“It has brought out the worst in the people around me, which is also a symptom of the
flaws in our society.”
Kiley: “No one hears our voices, I started to question my own sanity.”
Leslie: “The work and the relationships that came with my job were removed
from my life.” “Imagine being responsible for two babies with Lyme? I could not
remember if or when I fed my babies or changed their diapers.” “There were times where
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I felt as if I would never be normal and function in society again.” “My friend was a great
support in many ways, and I was able to slowly wean my way off all my meds while
recovering physically.” “Love goes a long way when it comes to healing.”
Marnie: “I find sharing with others is challenging because they have been
misinformed by the medical industry and it is like talking to a wall, sometimes they even
roll their eyes in distrust at me.” “It got to the point where I decided not to make any
plans because there was a good chance that I would be too sick to go, I lost a lot of
friends to this disease.” “My social life and hopes of a romantic partnership diminished
with my illness, I could not date I was too sick.” “My best friend lives in Vermont not far
from my LLND and she would go to appointments with me and became my advocate, she
also has Lyme.”
Rose: “At first, I was literally sick to my stomach to think that my sons thought I
might be crazy, or worse that they had no fit parent to raise them.” “My heart began to
understand the position of being marginalized and broke for both myself and others.” “[I
often communicate with others] who are ostracized from the medical community and
have nothing.”
Sabrina: “I am too tired and sick to hang with friends like I used to or spend time
alone treating myself to a massage, movie or a day out exploring.” “Most of my
colleagues were supportive, they even asked how they could help.” “I have a caring and
supportive wife who has been my rock through this journey.” “[I have] learned to be ok
with vulnerability and asking for help.”
Summary: With the exception of Sabrina, all of these women struggled with their
personal and professional relationships, and they were mostly affected for the worse.
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Study participants felt dismissed by their friends, family, and colleagues; some even lost
family and friends permanently. These sentiments resulted in a loss of self-esteem and a
feeling of no longer holding a rightful place in society. The extreme diminishment of
their social lives has an adverse impact on quality of life that cannot be underestimated.
Medical Struggles
Alice: “I get different answers constantly from different doctors.” “My life would
be drastically different today. Instead, I have been ridiculed and looked down upon by
many (doctors and nurses) while I have been fighting for my life, knowing there is no
treatment for me, no doctor that is willing to help me, and no insurance company willing
to cover any alternative treatments that greatly help my symptoms and recovery.” “[Now
that I am working with LLMDs, what is] most important is that they believe me.” “[The
only ones who want to] understand my dysfunctions in my body are LLMDs.” “After I
completed one full month of antibiotics, I was still only 30% functioning [and] I wouldn’t
be alive today without alternative treatments and doctors who treat alternatively and
wholistically.”
June: “[I was dismissed by so many doctors] I thought I was just dumb and had
to work twice as hard as everyone else.” “I feel utterly betrayed by the medical industrial
complex, the CDC and the FDA.” “I was put on doxycycline for three months and turned
in to a zombie overnight.”
Kiley: “I was blown off by most specialists we saw [and was] belittled and
laughed at by a specialist.” “I felt like I was losing my mind.” “Over the years I have
learned there is no point in debating the ‘Lyme Wars’ and I refused to be demeaned or
have my illness dismissed.”
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Leslie: “[My infectious disease doctor said] you look fine to me, if it makes you
feel any better I will write you a script for doxycycline.” “I was on an incredible amount
of antibiotics and supplements.”
Marnie: “After my Lyme diagnosis and subsequent treatment, the disease was
magnified a thousand fold. I was no longer the free spirit easy going over achiever
spontaneous human I once was.” “I could not decide if I wanted to die to feel better, or I
was going to die, either way, I just thought I was crazy.” “[My LLD] saved my life.” “My
LLD put me on pharmaceuticals occasionally when there would be the need, it was the
holistic approach that worked best for me.”
Rose: “[Meeting my specialized Lyme doctor] was my first glimmer of hope.”
“During my journey I have had three consecutive LLMDs, all who have been crucially
important on my path to health.”
Sabrina: “[After seeing four doctors] my current LLMD is the best physician I
have ever had in terms of listening and an equal partnership.”
Summary: In addition to coping with the physical pain and exhaustion of chronic
Lyme, these women conveyed in their narratives the extent to which their medical
struggles have been compounded by a medical industry that presents barriers at every
turn. They typically would get different answers from different providers, with no reliable
treatment, often accompanied by gaslighting and dismissal. They experienced having to
see an excessive number of doctors, even once diagnosed; in addition, they had to search
for a Lyme-literate doctor in order to get appropriate treatment. The costs to their
financial and emotional health were tremendously high, with corresponding impacts on
their quality of life.
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Work Ability
Alice: “I am still so sick I cannot physically work.”
Gloria: “No more tutoring, no more teaching, I cannot work, I cannot even sit in
my yard.”
June. “It was bad enough to lose my career, my profession, after working so long
and hard for it.”
Kiley: “Life is hectic and I want to be a better mom—I want to be able to not
completely collapse in exhaustion [from my job] and constantly be on the edge of chronic
pain.” “[I am afraid to take time off because I will] get backed up even further.”
Leslie: “There was no way I could do my job, I lost my cognitive functioning
along with my physical abilities.”
Marnie: “I could not remember what I said in a meeting, even when I wrote it
down I would lose the paper and then if I found it never know what the reference was for,
brain fog was humiliating and embarrassing.” “I actually left the job [before diagnosis]
on a day when I was in a fit of Lyme rage, at the time I had no idea why I acted that way,
the smallest things got me super frustrated.” “Being self-employed due to my illness
translates to days of illness equals no work, no money, and my treatments are expensive.”
“Work has diminished considerably at this time due to my Lyme anxiety and my inability
to drive.” “I certainly don’t have the self-esteem I used to.”
Rose: “The grieving was unquenchable…grieving the loss of my health, the loss
of my career and academic path.”
Sabrina: “I am unable to stand or walk for long periods. I can stand for up to five
minutes. Walking is a daily struggle.” “I worry about next school year, being in person,
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exposing myself to 1500 students who come in and out of the library. It is stressful and
scary.”
Summary: These excerpts represent and reflect the extent to which the women
participating in this study were incapacitated and could not work, or at best had to change
their ways of working, due to chronic Lyme. Most, at least for a period of time, kept
working despite illness, but eventually some were unable to maintain gainful
employment, with devastating financial consequences. Between loss of income and loss
of workplace health insurance, many were ultimately unable to provide for themselves
and/or their families. In addition, they lost professional identity, self-esteem, and a sense
of purpose. All of these consequences, and the acute accompanying grief, came at great
cost to their quality of life.
Access to Treatment
Alice: “Since I was working with one of the largest pharmaceutical companies in
the world, I had great healthcare. Yet, this only covered oral antibiotics and a few other
prescriptions.” “Alternative treatments are vital to my survival.” “I spent over $15,000 in
6 months on doctor visits, physical therapy, ER visits, and alternative treatments.” “[My
debt] feels like I cannot breathe and there is no point to go on in life.”
June: “IV treatments were $1000 per week out-of-pocket.” “I spent a fortune on
all the Lyme herbs.” “By now my inheritance was almost gone and we were on Mass
Health so I just cried.”
Kiley: “[The doctor] ran more tests than I have ever had done on me—over
$10,000 in lab work to be exact.” “Driving six hours each way every two weeks, getting
treatments, spending the night in a hotel, and then getting another treatment in the
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morning, and driving six hours back. After 8 months, and tens of thousands of out-ofpocket dollars, improvement was just not there.” “I was looking at bills over $450,000 for
six weeks of treatment. Does that sound like affordable care?” “It is so unbelievably
terrifying that I am out of options.”
Leslie: “There were many things I had hoped to do [for treatment] but did not
have the resources to.”
Marnie: “I would be deathly ill and bedridden if I could not have afforded my
specialized treatments.” “Lyme is called the rich man’s disease for a reason; you have to
have a lot of cash to pay for alternative treatments since western medicine does not
work.”
Rose: “I have no more money left to spend on expensive treatments, as I have
spent down my entire retirement savings to the point where I can spend no more. I live on
long term disability.” “My quality of life is gone.”
Sabrina: “I exhausted the in-network [insurance] options and was told by
specialists they could no longer help. I felt worse, and I felt it to the core, I did not have
an accurate diagnosis.” “My treatment has cost around $10,000 out of pocket in seven
months when everything should be covered by insurance.” “My parents are elderly and
now they have to spend their life savings on my illness.”
Summary: Access to appropriate medical care has been extremely difficult for
most of these women. After the challenge of being diagnosed, there is still the challenge
of securing the right treatment protocols with a Lyme-literate doctor. But beyond that,
these narratives point to the fact that lack of health insurance—or, even with insurance,
the need to pay exorbitant out-of-pocket costs—has pushed most of the women in this
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study to the point of financial devastation and bankruptcy. Financial constraints are a
major impediment to access to treatment, with quality of life suffering accordingly.

Integrated Analyses
The following discussion weaves together the Phase I, Phase II, and Phase III
research findings for the five research topics, providing an integrated analysis for each.
As demonstrated by these analyses, the mixed-method approach proved to be compelling:
each new phase of research both substantiated and enhanced the data collected in the
previous phase, leading to a more nuanced and comprehensive analysis of the issues at
stake.

Road to Diagnosis
Out of 373 anonymous survey respondents, 72% were medically diagnosed with
Lyme or Lyme-like diseases only after multiple misdiagnoses. 54% expressed the belief
that Lyme tests are ineffective and inaccurate; only 23% were diagnosed based on one
test. These experiences were echoed by focus group participants: eight out of nine
struggled with Lyme for a minimum of seven years before being properly diagnosed. All
nine had multiple systemic infections with chronic symptoms and had seen at least two
medical specialists.
The narrative responses provide further and more personal details about the
arduous road to diagnosis, and they add a crucial dimension about the experience: women
with chronic Lyme often face gaslighting. The Katz Institute for Women’s Health at
Northwell Health (n.d.) describes medical gaslighting succinctly: “Whether it’s heart
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disease labeled as anxiety, an autoimmune disorder attributed to depression, or ovarian
cysts chalked up to ‘normal period pain,’ many women’s health issues are likely to be
misdiagnosed or dismissed by doctors as something less critical” (section: Gaslighting in
women’s health: No, it’s not just in your head). Gaslighting was experienced to one
degree or another by all of the study participants who submitted narratives. As the
excerpts in the previous section indicate, their symptoms were dismissed, their concerns
were minimized, and, without a diagnosis, their chronic Lyme continued untreated and
became needlessly worse. Instead of working to identify the underlying cause of their
symptoms, numerous providers suggested that the women seeking their help had potential
hypochondriacal tendencies or psychological issues. It is no wonder that so many of the
participants experienced despair, hopelessness, and shame.
Moreover, gaslighting is fed by the skepticism that many in the healthcare field
have about whether chronic Lyme even exists, a debate explored earlier in this
dissertation. Chronic Lyme is undoubtedly difficult to diagnose, but it is no less real
because of that. Rose’s harrowing experience of having to consult with 30 doctors before
finally receiving a diagnosis may seem extreme, but as evidenced by the study results, it
is quite common for women with chronic Lyme to suffer for long periods of time before
being diagnosed, at great cost to not only their physical well-being but also their mental
health, finances, relationships, and overall quality of life. The consequences in some
cases have been catastrophic. Therefore, it is not surprising that 96% of women surveyed
indicated that they do not trust the medical industry to diagnose Lyme disease and LLDs.
Equally unsurprising, given the lengths to which they had to go to be diagnosed, 98% of
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study participants believed that specialized doctors were more knowledgeable about
treatment and diagnosis.

Relationships and Support
Relationships were investigated on multiple levels in this research, including
home, friendships, romantic partners, and casual acquaintances. The survey revealed that
only 27% of the women share their experience of Lyme disease with significant others,
contrasted to the data that they are more willing at 58% to share with others they know or
at 51% with new people in their lives. 83% of the women said they educate friends and
family on the disease. Tellingly, 62% believe they are seen and treated differently by
family and friends because of Lyme disease, 60% feel that family and friends have pulled
away, and 53% feel stigmatized by family and friends.
The focus group and narrative evidence provides more detail to these topics,
showing that this cohort of women was routinely met with resistance and skepticism.
Study participants in both focus group and narrative formats expressed their deep
frustration that others in their social sphere neither understand nor care about the
significance of a chronic Lyme diagnosis. Moreover, encountering disbelief or questions
about the legitimacy of one’s illness can have adverse consequences for one’s mental
health, as many study participants experienced. As a Lyme advocate, Marnie noted that
she encounters a great deal of misunderstanding about the disease, particularly given the
prevailing public opinion, encouraged by the medical industry, that Lyme is easily treated
with a two-week course of antibiotics. “The resistance is palpable,” she said.
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A repeated problem identified in both the focus groups and narratives was that
study participants lost significant relationships due to Lyme disease, recounting how
terribly alone they felt as a result. Many were highly accomplished, successful in their
academic and professional spheres, yet were forced to abandon their careers and
aspirations, losing financial stability in the process. Demographic data from the survey
revealed that 69.2% of the participants were in household income brackets of $75,000 to
$100,000 before Lyme depleted their economic resources. Marriages, family connections,
and friendships all suffered, sometimes irrevocably. All seven focus group participants
said that important relationships had deteriorated or ended; five out of the seven lost their
romantic partnerships or chose to not have one.
These social impacts are profound. One of the greatest markers of personal
satisfaction as a quality of life indicator is relationships:
The benefits of social connections and good mental health are numerous. Proven
links include lower rates of anxiety and depression, higher self-esteem, greater
empathy, and more trusting and cooperative relationships. Strong, healthy
relationships can also help to strengthen your immune system, help you recover
from disease, and may even lengthen your life. (Better Health, 2017, section:
Health benefits of strong relationships)
In contrast, Novotney (2019) describes adverse health consequences from social isolation
“including depression, poor sleep quality, impaired executive function, accelerated
cognitive decline, poor cardiovascular function and impaired immunity at every stage of
life” (section: Effects of loneliness and isolation).
Many of the women recounted their daily struggles to curb their anxiety, and all
seven focus group members used meditation or other stress-reducing activities to
counterbalance the strain they felt from being alienated and to help them occupy their
time in a healthy way. In so doing, they echo Horowitz’s (2013) counsel that “Working
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with the mind and learning to find peace in the midst of pain and suffering is essential
when dealing with significant illness” (p. 445). Another form of coping is to forge
connections with others within the Lyme community, and the focus group meetings were
a very lively and engaged example of that. In addition, most of the women have become
their own advocates and researchers of the disease—a coping mechanism, certainly, but a
survival tactic as well.
Unlike for most of the women participating in the focus groups and narratives,
Sabrina’s experiences with social relationships in the wake of chronic Lyme have been
largely positive, offering hope for a better relational paradigm for the future (which is not
to say that her journey with Lyme has been a smooth or easy one). She had a doctor who
advocated that she be tested for Lyme and co-infections, a rarity. Her family and wife
were very supportive of her quest to get diagnosed and have sustained their investment in
her well-being during her treatment. In addition, Sabrina’s job was such that she was able
to work remotely during the first part of the pandemic, an opportunity that others in the
study did not have.

Medical Struggles
While this topic has overlap with the Road to Diagnosis, it is also important to
consider on its own because, however long it may take to be diagnosed with chronic
Lyme disease, there is still a lifetime of subsequent medical management to come. Of the
women surveyed, only 2% believe that Lyme is taken seriously by the medical industry,
and 89.5% do not trust the medical industry.
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There was not one woman who participated in the focus group or provided a
narrative account who was uniformly satisfied with her medical encounters. Even after
diagnosis, a number of study participants had doctors who did not believe the result or
who doubted or minimized their symptoms—as strong, intelligent women, they were
gaslighted and their very sense of reality was undermined. This shared experience
generated some of the most animated discussion in the focus groups. It is no wonder,
then, that of the women surveyed, 36% chose to seek out a specialized doctor due to
dismissive doctors elsewhere, and 44% chose a specialized doctor because they lacked
trust in their primary care physician.
It is important here to point out the distinction between specialist providers—i.e.,
cardiologists, neurologists, endocrinologists, orthopedists, psychologists, psychiatrists,
infectious disease experts, etc.—and specialized providers, who are explicitly Lymeliterate doctors (and who may or may not also be specialists). As Chesney (2020) notes,
“Lyme-literate practitioners, by definition, support the idea that Lyme can continue to
cause illness in the body past the initial acute phase of diagnosis or treatment” (p.164).
The study participants who found their way to a LLMD, LLND, or LLD had a better
experience. In the survey, 56% of those who saw a specialized doctor believe that the
specialized doctor was knowledgeable about Lyme and Lyme-like diseases, and all six
focus group participants had sought out specialized providers. As Horowitz (2013)
explains, “When you have been trained in a particular medical specialty, you see the
world through certain lenses and diagnostic paradigms” (p. 22). This could account for
many of the medical experiences study subjects had, both good and bad.
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Another dimension of the medical struggle is determining the most effective
course of treatment for chronic Lyme disease, including both conventional and alternative
therapies. Chesney (2020) writes, “Within the Lyme-literate community there has been a
bridging of conventional medicine and natural therapies. Past the initial phase of Lyme
disease, a holistic approach has been realized to hold incredible value and importance”
(p. 164). In the focus group, all six participants had minimal success with
pharmaceuticals, faring better with alternative protocols, a finding echoed in the survey,
where 60% of respondents trusted alternative treatments compared to 12% who trusted
traditional treatments. Whether the treatment approach will actually work is another
question; chronic Lyme can be intractable. Rose, for example, took oral antibiotics for
five years, herbal supplements for five years, and then was on a combination of IV
antibiotics and herbal supplements for another five years.
The best success stories of treatment were those with Lyme-literate providers. As
women in the focus group conveyed, even small improvements made with Lyme-literate
providers improved their outlook on life. Having one’s experience validated can be
deeply affirming, and any degree of treatment success can feel quite significant when one
is severely ill. The very fact of being believed increases optimism. And, in turn, optimism
supports improved quality of life:
Optimism increases job performance, creativity, ability to weather stress & selfesteem. Optimism can be used in how you talk to yourself in the face of adversity,
explain past events & think about the future. In the quest for the good life,
positive expectations can be self-fulfilling. Cultivating your ability to be
optimistic is beneficial to your health & your success (Stratejoy, first item:
Cultivate optimism).
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Work Ability
In responding to the research survey, 75% of women indicated that the disease
interferes with their ability to do their job, 65% believe their abilities to work are limited
due to their disease, and 55% reported that they are limited in where they can work. 78%
reported that they try to work through their disease symptoms even when doing so is
detrimental to their health. Even so, 62% had to take time off because of illness; 50%
reported they were afraid to take time off.
In the focus group and written narratives, the heartbreak associated with this loss
of professional ability was palpable. Five of the seven women asked for workplace
accommodations. All seven either reduced their hours or left their employment
altogether. Social capital has been defined as “the set of cooperative relationships
between social actors that facilitate collective action. This concept has been measured
based on five dimensions: trust, social relations, commitment, communication and
influence…Higher levels of social capital imply greater levels of satisfaction and quality
of life at work” (Requena, 2003, section: Abstract). Social capital is either diminished or
lost altogether with a diagnosis of chronic Lyme. Alice, who had a high-powered job at a
pharmaceutical company and was en route to a PhD, eventually could not even spell her
name. Sabrina loved her job as a librarian and worked remotely during the pandemic, but
once schools resumed in-person instruction she could not meet the physical demand of
standing for extended periods of time. This led her to look for other positions that she can
perform remotely.
All of the study participants whose work ability was compromised by chronic
Lyme invariably experienced depression, shame, disgrace, and a feeling of inadequacy; it

86

is difficult enough to combat a chronic illness, but to lose one’s livelihood when the
treatments and personal costs are so extreme is incomprehensible. Chronic illness
advocate Charis Hill describes it this way: “For people who struggle every day to get out
of bed (or not), manage their health, share an educational post online, and keep a roof
over their heads; their most important job is life or death, not paycheck vs poverty.
However, many patients in these situations are fighting both for their life and struggling
financially. They exist in a life or death and ‘paycheck’ vs poverty continuum” (as quoted
by Basile, 2020, 6th paragraph).

Access to Treatment
The extensive costs associated with lengthy treatment protocols for chronic Lyme
disease have limited access to treatment for a number of study participants. Of those
surveyed, 80% believe that medical bills are not affordable for treatments. 56% of those
seeing a specialized doctor did not believe it was affordable, and 54% did not see a
specialized provider due to lack of affordability. Some participants lost insurance by
virtue of having to leave work, but even for those with insurance, the coverage was
inadequate for many; 42% of treatments at the time of the survey were covered by
insurance and 32% of treatments at the time of the survey were not covered by insurance.
Indeed, the loss of employment and depletion of resources that many study
participants experienced caused some to move from a position of financial stability to
becoming low-income, further limiting access and affordability. As Kearney et al. (2021)
note, “Medical bill problems … disproportionately affect those without health insurance,
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those with lower household incomes, and adults in households where they or a member
of their household has a serious health condition” (6th paragraph).
Of the ten women in this focus group, ten out of ten either had no insurance or
limited insurance as a result of leaving their job due to chronic Lyme. Without coverage,
essential treatment(s) came at great cost. Eight had limited their treatments due to
inadequate insurance coverage. Seven expressed dismay at the prohibitive cost of
wholistic and alternative treatments, which are typically not covered even when one has
insurance. Six out of the ten disclosed that they had exhausted personal savings and
retirement accounts and/or liquidated assets. Even for someone like June, who began her
Lyme journey with substantial personal assets, costs quickly overwhelmed resources.
Kearney et al. (2021) have reported that “Nearly half (46%) of insured adults report
difficulty affording their out-of-pocket costs, and one in four (27%) report difficulty
affording their deductible” (5th paragraph); and “Those in households where someone has
a chronic condition are more likely than their counterparts to report negative impacts
from their inability to pay for medical bills” (section: Problems paying medical bills, and
their consequences). For some of the women in this study, in order to obtain treatment,
they either had to cut other core living expenses or assume significant debt, a choice
between negative options with clear ramifications for stress and well-being.
Overarching all of these medical struggles is the grief that comes from losing
one’s independence, a sentiment expressed repeatedly and eloquently by study
participants Grieving the old personality and making peace with the “new normal” is
deeply complicated and emotionally fraught. As Livingston (2012) puts it, “All the
complexities of the individual spirits, strengths and flaws are obscured as that ill person
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becomes the disease or condition, rather than the person he or she was before the
diagnosis” (section: Fear of pity).

Summation of Findings
As of today, January 17, 2022, there are 476,000 cases of Lyme disease reported
per year, according to the CDC, and many professionals believe the true number is
markedly underreported. In ten years, that number will be close to five million.
Nor does that incidence account for cases of chronic Lyme. Writing in 2019,
DeLong et al. state:
… [A] sizeable number of patients [with Lyme disease (LD)] experience
treatment failure and continue to suffer long-term, debilitating symptoms,
including pain, fatigue, cognitive dysfunction and other symptoms. This is known
as post-treatment LD (PTLD), for which diagnosis is not standardized and
treatment remains controversial. The prevalence and societal burden of PTLD is
unknown….
In an effort to help characterize the LD landscape, we estimated the number of
PTLD cases in the US in 2016 and 2020 using Monte-Carlo simulation
techniques, publically-[sic] available demographic datasets, uncertainty in the
inputs and realistic assumptions about incidence and treatment failure rates.
… Prevalence in 2020 is predicted to be higher than 2016, and may be as high as
1,944,189 (CI [cumulative incidence] 1,619,988 to 2,304,147) cases. (section:
Abstract)
This is a public health problem not to be denied.
As detailed above, the quantitative and qualitative data collected for this
dissertation were coded and analyzed using a quality of life classification system I
developed and applied consistently across all three phases of research. These data were
then aligned with the five research topics: Road to Diagnosis, Relationships and Support,
Medical Struggles, Work Ability, and Access to Treatment. The scope of quality of life
issues under consideration was broad, encompassing socioeconomic factors such as
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demographic data (age, education, economic status, etc.) as well as encounters with the
medical system and medical providers (including alternative medicine), impacts on social
and familial relationships, the ability to work, and financial access to health care
resources.
The three research phases proved to have a cumulative effect, with each verifying
and reinforcing the data collected. Throughout, the findings were consistent and
compelling, demonstrating that the chronicity of Lyme and Lyme-like diseases has
negatively affected the quality of life for the women who have it. While not broadly
generalizable from a scientific standpoint, it is clear that, at least among this study cohort,
there is a striking pattern of repeated, often years-long misdiagnosis, accompanied by
others’ disregard for the reality of the experience and acute quality of life impact, from
loss of core relationships to the inability to work to financial disaster. Inevitably, we must
assume that women who were not part of this study also experience similar
socioeconomic impacts from chronic Lyme disease.
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CHAPTER 5
IMPLICATIONS AND CONCLUSIONS
The main impetus for this dissertation research was to eventually write a
comprehensive and thoroughly researched book. Having additional academic experience
and intellectual rigor has definitely assisted me in that quest. As I stated at the outset, my
primary goal has been to document the impact of chronic Lyme disease on women’s
quality of life in a way that is accessible to the public, medical professionals, and policy
makers alike. And indeed, this research both validates and strengthens the need for such a
chronicle. My greatest hope is that this work and the forthcoming book will serve to
educate the public about what it means to suffer from chronic Lyme and associated
diseases, and in so doing increase understanding, empathy, and advocacy; give
knowledge and tools to health care providers and others who diagnose, treat, and care for
persons with Lyme; offer hope and information to people lost in the maze of a widely
misunderstood and dangerous disease; and, ultimately, improve and save lives.

Summary
My starting point for this dissertation was one overarching question: How does
chronic Lyme disease (including Lyme-like diseases), affect the quality of life of women
who have it? Secondarily, I asked: What are the experiences of the women who have
chronic Lyme disease? What are the major quality of life issues women with chronic
Lyme disease face? And what are the socioeconomic obstacles created by the disease? As
a woman with chronic Lyme disease who has had to navigate a difficult medical and
social system, I have first-hand experience with the ways Lyme has affected my own
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quality of life. But I wanted to approach these questions scientifically and more
expansively.
I began by conducting an informal poll of members of the Women and Lyme
Disease online support group, to which I belong, asking women to identify the major
issues they have faced in dealing with their disease. Five broad topics were identified:
difficulty getting diagnosed, impact on relationships, struggles with the medical system,
consequences for work, and barriers to getting treatment.
To examine these topics, I utilized a mixed methods research approach combining
quantitative and qualitative methods, conducted across three distinct phases. This method
provided a vigorous, comprehensive, and multifaceted approach to the findings and
analysis. Phase I was the quantitative portion of the study: an online survey instrument
that asked a large number of questions encompassing the five topics, and which resulted
in a robust data set. The results were critical to refining the research topics—Road to
Diagnosis, Relationships and Support, Medical Struggles, Work Ability, and Access to
Treatment—and crystalizing the most important quality of life issues within each topic.
The qualitative portion of the study was conducted in Phases II and III. Phase II utilized
five focus groups, each consisting of a guided discussion of one of the topics, with the
discussion framework and prompts based on the survey results. As such, they further
distilled the essential issues, capturing a great deal of nuance in the process. Conducted
concurrently with Phase II, Phase III used the method of compiling personal narratives,
demonstrating just how dominant these topics are within individual women’s lives, as
conveyed through their own voices.
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To investigate quality of life, it is important to first understand a person’s wellbeing status. The CDC’s (2018d) definition of well-being, which is discussed in Chapter
1, includes physical, emotional, economic, and social well-being and satisfaction in most
areas of life—in essence, thinking of life positively and feeling good—all of which are
important to being a successful, vibrant, and productive member of one’s chosen society.
Well-being includes the assumption that one’s life will have a large percentage of time
free from the inconveniences and stresses of chronic illness. Therefore, all three research
phases in this study asked questions and analyzed data with both the CDC’s definition of
well-being and the complexities of health-related quality of life in mind.
Chapter 2 discusses the “Lyme Wars”—the ongoing controversy in the public
health and political spheres about whether chronic Lyme disease even exists—but this
dissertation is predicated on the belief that it does: the lived experiences of women with
chronic Lyme is at the heart of this research. Next is a review of the literature on quality
of life, including the impact of chronic illness on quality of life for women. What was
shocking about the literature review was how extraordinarily little research there is with
regard to chronic Lyme disease and quality of life. As detailed in Chapter 2, the notable
exception is a 2014 study conducted by Johnson, et al., “Severity of chronic Lyme
disease compared to other chronic conditions: A quality of life survey,” which concluded
that patients with chronic Lyme disease have significantly impaired health-related quality
of life relative to both the general population and. patients with other chronic diseases.
My research found that the same adverse impacts Johnson, et al. reported were
commonplace for women with chronic Lyme disease. In addition, my study went beyond
health-related quality of life indicators to also consider relationship stressors, difficulty
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with diagnosis, impact on the ability to work, and barriers in the medical system, and
demonstrated that quality of life was diminished across all domains.
In documenting the experiences of the women who participated in this
dissertation research, it became increasingly apparent that the medical industry is
performing services in a way that does not believe chronic Lyme disease exists.
Misdiagnosis, misinformation, and mistreatment abound; in addition, consistent and
ongoing experiences of dismissal, disbelief, and gaslighting further undermine their
quality of life.
Lyme Wars is not just a political debate: health and quality of life are at stake.
Steven Philips, a Yale-trained physician and researcher whose specialty is the treatment
of complex vector-borne infections (and who has served as a Lyme disease expert for the
states of Connecticut, New York, Rhode Island and Vermont), describes this reality in a
2020 opinion piece entitled “Lyme disease patients fight for their lives while academics
fight each other,” excerpted below:
For patients, there is often nothing more soul-crushing than being inexplicably
sick with doctor after doctor having no answers, or getting the wrong diagnosis
and being led down the wrong path with the wrong drugs. But for patients with
Lyme disease, either or both is common, because its every aspect has been so
bitterly contested…
…
So what does this mean for patients who are living with chronic illness after
having failed the Infectious Diseases Society of America recommended short
course of antibiotic treatment for Lyme? The number of patients living with
chronic Lyme is staggering, with estimates as high as 2 million people in the U.S.
alone. And these patients are often very sick, with profound quality of life
impairments which studies 5 show can be more severe than for many other chronic
diseases.
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Notably, the hyperlink in the article leads to the Johnson et al. (2014) study; the fact that
no additional research has been conducted since 2014 further demonstrates how
disregarded chronic Lyme disease is.
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…
Clearly, we need more and better research into this polarizing—and frequently
disabling—modern plague. The question is why this research isn’t being done,
given the scale of the problem and the length of time we’ve been aware of the
disease. It’s scandalous that, for such a common and serious chronic infection,
over the past 20 years there have been only three NIH-funded randomized
controlled trials evaluating antibiotic re-treatment of Lyme patients who remain ill
after a short course of antibiotics…
…
[Until] we stop regarding sick patients—and their doctors—with suspicion based
on outdated understandings on how “every” bacterium functions in the body and
responds to antibiotics, bias and not science will determine how we respond to
this ongoing plague. (1st, 11th, 14th, and 20th paragraphs)
In 2013, Horowitz wrote, “Lyme disease has been ignored or trivialized by the medical
profession for more than a quarter of a century” (p. 1). Stevens demonstrates that, almost
a decade later, nothing has changed.

Discussion
This dissertation weaves together the findings from three phases of research,
comprising both quantitative data collected by means of an anonymous survey (Phase I)
and qualitative data in the form of personal accounts collected through phenomenological
focus group discussions (Phase II) and written narratives (Phase III). Each of the research
phases delved into five topics that have significant implications for quality of life: Road
to Diagnosis, Relationships and Support, Medical Struggles, Work Ability, and Access to
Treatment. The integrated analysis of the findings depicts with great clarity the many
difficulties facing the women with chronic Lyme disease who participated in this study.
As such, this research was successful in conclusively answering the questions posed at
the beginning of this dissertation, demonstrating the impact on quality of life both within
and across the five research topics. While not scientifically generalizable to all women,
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the results certainly suggest that chronic Lyme disease has an adverse impact on many
aspects of quality of life for the women who have it.
My research bears witness to the tangled web of medical nightmares experienced
by so many women with chronic Lyme disease. For many, the first hurdle is getting a
proper diagnosis, which can require years of self-advocacy. But even receiving a
diagnosis does not mean one’s condition is necessarily taken seriously by conventional
medicine. As is seen repeatedly throughout this study, women were told they do not have
the disease and, even more so, that they may have psychological or other issues. In
addition, my research demonstrates that any given impact on quality of life will almost
certainly influence the others, creating a multiple-layered, trickle-down, domino effect of
systemic problems.
A case in point is Rose, thriving professionally as a highly regarded schoolteacher
and doctoral candidate with financial security. She presented herself with confidence,
was socially adept, and had a family and valued friends and colleagues. Rose lost
everything to Lyme disease. Just the extraordinary effort it took her to secure a definitive
diagnosis—which only occurred after 30 misdiagnoses—bankrupted her. She could no
longer afford her comfortable home. She became disabled and could no longer work or
pursue her graduate studies. She became alienated from her family, and loneliness crept
in. Or consider June, a smart and accomplished woman who had Lyme symptoms from
childhood but went undiagnosed or misdiagnosed for 17 years. Her disease came at the
cost of her career, her family, and her life savings, which included a large inheritance.
The cascading impact of chronic disease includes “physical, psychological and social
functioning—they are affected by one’s disease and/or treatment” (Megari, 2013, p. 14).
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It is vitally important for those with chronic illness to be able to navigate life with
as little disturbance and distress as possible, to receive love and support, and to
experience wellness as much as possible, in order to enjoy a standard degree of quality of
life and to heal their disease. However, as I know very well from my own struggles with
chronic Lyme, and is evident for so many of the participants in this study, the overlay of
an unnecessarily complicated and challenging healthcare system, coupled with a lack of
support in every aspect of life, is devastating. Throughout all three phases of this
research, I repeatedly learned about the many ways quality of life for women with
chronic Lyme disease is affected in intersecting and compounding ways, with significant
adverse socioeconomic consequences. Table 3 is a compilation of my observations of
these issues and experiences.
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Table 3: Compilation of Impacts of Chronic Lyme on Women’s Quality of Life
Elements of a Good
Quality of Life
Good health…
 Body functioning well
 Physical integrity
 Living without pain
 Access to affordable
health care

Emotional well-being…
 Sense of self-worth
 Love of life and self
 Mental health and
psychological stability
 Contentment
 Spirituality

Chronic Lyme’s Adverse
Impacts on Quality of
Life

Related Adverse
Consequences for
Quality of Life

 Chronic pain
 Coping with multiple
illnesses/diseases
 Need for multiple medical
visits
 Frequently undiagnosed
or misdiagnosed by
health care providers
 Receiving conflicting
medical advice
 Difficulty finding a Lymeliterate provider
 Medical uncertainty,
anxiety, and fear

 Many wasted years
chasing diagnosis
 Disbelieved or dismissed
by health care providers
 Unnecessary suffering
 Undergoing unnecessary
testing and treatment or
denied needed treatment
 Prescribed wrong
medications
 Being depersonalized
 Gaslighting, leading to
doubting one’s sense of
reality
 Being viewed as a
troublesome patient
 Being pathologized, e.g.,
being told one is anxious,
depressed,
hypochondriacal, bipolar,
imagining things

 Grieving one’s former self
 Emotional pain and
suffering
 Diminished experience of
joy or happiness
 Loss of hope and
optimism
 Experiencing “Lyme
anxiety”
 Poor sleep
 Negative impact on
psychological health
 Negative impact on mood
and outlook

 Losing sense of self in
one’s illness
 Having to channel all
energy to self-advocacy
 Being overwhelmed by
time and effort of coping
with disease
 Sense of despair and
feeling defeated
 Sense of worthlessness
 Fear of dying
 Risk of suicidal ideation
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Elements of a Good
Quality of Life
Social connectedness…
 Sense of belonging
 Participation in shared
activities
 Loving and feeling loved
 Healthy relationships,
including with romantic
partners, friends, and
family

Sense of safety…
 Comfort in one’s
environment
 Ability to move through
life freely
 Having a safe home
 Not living with fear
 Overall sense of security

Chronic Lyme’s Adverse
Impacts on Quality of
Life

Related Adverse
Consequences for
Quality of Life

 Inability to participate in
social activities
 Disbelieved and
dismissed by romantic
partners, family, and
friends
 Experience of illness
being trivialized or
minimized by others
 Loss of social network

 Social isolation and
loneliness
 Lack of support in dealing
with illness
 Threatened or ruptured
relationships with
romantic partners, family,
and friends
 Rejection and
abandonment
 Being scapegoated or
blamed for one’s
condition
 Being socially
marginalized
 Being stigmatized and
ostracized

 Loss of physical
capacities
 Physical limitations and
diminished capacity
 Difficulty or inability to
perform daily activities
 Full disability

 Loss of independence
 Need to relocate or
downsize
 Risk of homelessness
 Risk of being subject to
violence
 Sense of vulnerability
 Feeling fearful and
unsafe

Access to adequate resources…
 Financial stability
 Burden of expensive
 Material needs met (food,
testing, treatment, and
clothing, water, shelter,
medications
etc.)
 Financial hardship
 Ability to live as one
 High insurance copays or
chooses
requirement to pay outof-pocket for care
 Need to travel long
distances for treatment
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 Change in economic
status
 Inability to pay for
needed treatment and
services
 Severe debt
 Bankruptcy
 Food and housing
insecurity
 Inability to support one’s
family

Elements of a Good
Quality of Life

Chronic Lyme’s Adverse
Impacts on Quality of
Life

Fulfilling professional and academic pursuits…
 Participating in
 Cognitive decline
meaningful work or
 “Lyme fog” causing
scholarship
difficulty thinking clearly
 Chronic exhaustion
 Being a productive
 Working despite illness
member of society
Disbelieved and
 Intellectual stimulation
dismissed by employer
 Earning a living wage
and colleagues
 Health insurance
 Loss of employment
 Inability to maintain
career trajectory
 Inability to continue in
school
 Loss of health insurance

Related Adverse
Consequences for
Quality of Life
 Workplace discrimination
 Rejected or unsupported
by colleagues
 Loss of professional
identity
 Unemployment or
underemployment
 Loss of dreams and
aspirations
 Loss of self-confidence
 Feeling embarrassed,
humiliated, and shamed
 Feeling guilty for impact
of work status on
romantic partnership and
family

As we have seen, Lyme disease diagnosis and treatment are laden with
divisiveness and contentiousness. The women in the study overwhelmingly had an
abundance of problems that stemmed from the mishandling of their disease by the
medical industry, combined with public misinformation that seriously hindered their
professional and personal relationships. This is seen in the Road to Diagnosis analysis,
where all of the women consulted with many doctors over extended time periods,
contending with multiple misdiagnoses. It is also seen in their frequent encounters with
gaslighting and dismissiveness by doctors and others. The damage did not stop there,
with tales of woeful negligence by the medical industry accompanied by workplace
stigma, loss of relationships, and financial hardship, in some cases resulting in loss of
health insurance, inability to pay for treatment, bankruptcies, and homelessness.
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Ironically, the mishandling of Lyme disease has itself become an epidemic, which
sincerely resonates with these research findings. It was my intention to examine the data,
expecting to identify detrimental factors but also anticipating finding promise in the
personal stories. Sabrina’s early diagnosis coupled with her doctor’s advocacy, her
supportive partnership, and her parents’ financial help is such an example, but, even so,
that optimistic beginning quickly became overshadowed. She and her family were
overwhelmed by subsequent adversity: her health was weakened considerably and her
parents had to spend their retirement savings for her care.
What is promising and inspirational is the strength of character and tenacity in the
face of hardship present in the hearts of these women. The focus groups dealt with
difficult experiences and participants were sometimes brought to tears. Still, the tenor
was often one of resilience, inquiry, and creativity. Not infrequently, a woman would
remark how difficult it was to tell the story of her dreadful journey with this horrible
disease and the failures of a fractured health care system. However, to a person, they
decided to share their experiences so that others can learn and find hope. These women
have persevered and become their own advocates. Even with diminished capacity in
many dimensions of their lives, they have faced the obstacles with grace, dignity,
tenacity, and a powerful spirit.

Implications for Future Research and Policy
The findings reported here are relevant to health care practitioners, patients,
educators, social service providers, and policy makers, as well as the general public. This
study illustrates that the misdiagnosis, misinformation, mistreatment, and
misunderstanding associated with chronic Lyme disease are profound and have a harmful
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effect on the women who have it. In order for women, and all persons, to have access to a
swift and accurate diagnosis and equal and affordable treatment, education and policy
change is a must.
This research unquestionably justifies examining more deeply the adverse effects
of Lyme disease on women’s quality of life. The questions were fashioned to elicit
information about the most serious issues facing the women in the study and the social
and economic implications of such. Also, I wanted to not just identify the issues but ask
for details about how these women have been affected and what that has meant in their
lives. Women with Lyme disease are a marginalized population: I found that despite their
previous economic stature, many are now low income, living in substandard conditions
given their age and physical limitations, disabled, and alone, with little or no assistance.
This study reflects with specificity the battles these women face, not just in terms of
health-related quality of life but across the five specific research topics and the broader
socioeconomic implications they contain. It expresses in detail the human cost of
inadequate medical and social service provision.
Further, I am confident that both individual and systemic injustices, poor
education for medical professionals, and unsatisfactory health care practices are to blame.
Cooper and Morton (2021) state, “The seeds of the economic discontent felt by so many
in the US can likely, in part, be traced back to the health care system” (opening
paragraph). A joint report by the US Department of Health and Human Services, US
Department of the Treasury, and US Department of Labor (2018) observes, “As health
care spending continues to rise, Americans are not receiving the commensurate benefit of
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living longer, healthier lives” (section: cover letter, p. 1). It is a beginning to identify the
problems, but then it is essential to create solutions to rectify them.
A transformation at the policy level is necessary to improve quality of care. A
Tick-Borne Disease Working Group was established by Congress in 2016 “to improve
federal coordination of efforts related to tick-borne diseases” in order to “minimize
overlap, examine research priorities and identify unmet needs” (HHS, 2017). The
working group is authorized through December 2022.
Several strategies would be particularly helpful. A first step would be to identify
why there are such polarizing views and approaches to Lyme disease treatment, both
chronic and acute. There needs to agreement at all levels—from individual practitioners
to national policymakers—in order to have a consolidated response. To date, grassroots
efforts have been the primary motivator to addressing Lyme issues; however, a largescale, organized standard that acknowledges and accepts the reality of chronic Lyme
disease is mandatory. An example of this approach is presented in a study of Canada’s
Maritime provinces response to Lyme, for which the first step was to conduct “a review
of the literature, both academic and gray … to illustrate the current scholarship
surrounding Lyme disease in order to better understand why Lyme disease has become
such a polarizing issue” (Levesque & Klohn, 2019, section: introduction).
A second approach would be to garner more legislative involvement and secure
increased funding. For example, Christopher Smith, Republican member of Congress
from New Jersey’s 4th District, sponsored an amendment, subsequently passed by the
House of Representatives, to increase funding for Lyme disease research at the CDC by
$4 million for fiscal year 2021. The allocation brought the agency’s research budget to
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$20 million, up from $11.7 million three years prior. As he said in the news release, “The
increase in funding … will help CDC develop better diagnostic tests for Lyme, expand
tick surveillance activities across the US and strengthen the federal government’s overall
strategy to combat Lyme” (Smith, 2020b, 2nd paragraph). He also introduced a successful
amendment to the 2020 National Defense Authorization Act “mandating a GAO
[Government Accountability Office] investigation into possible use of ticks in the
bioweapons program” (Smith, 2020a, 10th paragraph), an action inspired in part by Kris
Newby’s 2019 book, Bitten: The Secret History of Lyme Disease and Biological
Weapons.
A third approach would involve streamlining and consolidating standards for the
treatment of Lyme disease by physicians and others in the medical field, including a
concerted effort to dispel myths and untruths. A particular focus should be on
disseminating information about the signs and symptoms of Lyme disease, to both
professionals and the public at large. Lyme disease is a clinical, symptom-based
diagnosis, but far too many doctors dismiss patients based on the results of antiquated
and unreliable testing. Investment in a system of practices that allows for prompt
diagnosis along with acknowledgment of and mechanisms to respond to the host of other
issues identified through this research would have countless benefits: better access to
affordable and quality health care; better quality of life and longer lives for those with
chronic illness; policies to address the real needs of people who are marginalized, with
funding to assist them; a healthier cohort of individuals who can contribute to society—
and the list goes on. Certainly, structured change would be one step toward resolving
some of the imbalances found in my study.
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Fourth, starting at the elementary school level, parents, students, teachers, school
medical personnel, administrators, and staff should all be trained to identify the signs and
symptoms of Lyme disease. An awareness program in the schools would have immediate
and beneficial results with regard to the prevention, early diagnosis, and treatment of
Lyme disease in children. Although my research did not include participants under the
age of 18, the increasing numbers of children with Lyme disease is of significant concern.
What happens next for the women in this study, who deserve a better quality of
life? Or for the indisputably significant numbers of other people adversely affected by
chronic Lyme disease? Malcom Gladwell (2000) writes “What must underlie successful
epidemics, in the end, is a bedrock belief that change is possible, that people can radically
transform their behavior or beliefs in the face of the right kind of impetus” (p. 258).
Reforming policy to include chronic Lyme as a legitimate illness must be one
such “bedrock belief.” Education and training are needed for doctors and other health
care practitioners in a united effort to recognize and treat the disease appropriately. This
is no easy task, but there are thousands of individuals, much like myself, who have
single-handedly taken on the mission to get answers and solutions, for ourselves and
others. Baltimore Magazine (2014) recounts the journey of Susan Green, an attorney
whose life was upended by Lyme. Once she regained her health, she became an advocate
for Lyme policy reform, including introducing a bill in the Virginia legislature requiring
doctors to disclose the limitations of Lyme testing, an effort she described as “one of the
hardest battles I’ve ever fought in my entire career” (19th paragraph). Among participants
in my study, Rose started an advocacy group, Sabrina educates friends and colleagues, at
least two survey respondents have opened a resource center, and I am writing a book.
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The fact that there is so little literature about the quality of life impacts on women
with chronic disease, much less about women with chronic Lyme disease, indicates how
relevant this study is. My dissertation contributes to the academy by exploring an issue
that is virtually unstudied: the convergence of women with chronic illness, Lyme disease,
and quality of life, and the consequences thereof. The lack of existing research makes this
study even more relevant and interesting. It also indicates how broad a foundation exists
for more discovery of the issues.
Regardless of the generalizability of these findings, one can and should infer that
what this research has revealed is just a small snapshot of a much larger problem. Future
research can focus on resolutions to the problems identified herein. Expansion of the
literature on the specific impacts of Lyme disease and quality of life would be another
step. Much has been written about women’s experience of being dismissed and belittled
by the medical industry, but not about that experience with regard to Lyme disease; a
comprehensive and focused study on this matter would be valuable. Coping strategies for
managing reduced quality of life for women with Lyme disease would be another good
topic for investigation. Last but by no means least, research and resources directed
toward comprehensive training for providers, accurate and complete education of the
public, and policy change at all levels should be mandatory.

Concluding Thoughts and Reflections
I once read that, during the course of a dissertation, you have to continually ask
yourself: “So what?” and “Who cares?” For me the motivation for undertaking this work
was obvious and borne out of personal experience: I want to change a system that is
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broken, unjust, and unnecessary. Gladwell (2000) discusses that the world seems like it is
“immovable” but asserts: “It is not. With the slightest push—in just the right place—it
can be tipped” (p. 259).
This was my intention. However, first I needed to identify, justify, and validate
the problem beyond the level of anecdote. In order to make my work significant and
credible to an audience of scientists, it was imperative to gather quantifiable data, test the
premise, and analyze the findings according to standard methods. This, in turn, would be
the basis to shape the questions for collecting and substantiating the subsequent
qualitative data.
I truly believe that there must be a global consciousness to successfully address
the scourge of Lyme disease, and the urgency to do so is only increasing. Currently we
are in the midst of the global COVID-19 pandemic, and there is much to be learned from
the medical treatments, social policies, mistakes, controversies, and successes of
managing this crisis that can inform future approaches to treating the ever-growing
epidemic of Lyme disease. I hope to become involved in COVID research and apply its
parallel lessons to Lyme disease.
*

*

*

I have seen how lives have been lost, literally and figuratively, and always
unnecessarily, to chronic Lyme disease. Who is responsible? The answer lies in the
power of context; ideas and experiences are what move us to action.
Not long ago, I was riding my bicycle on a beautiful late summer day, anticipating
the autumn scenery to come. It is such a beautiful sight to see the leaves changing colors
in the Western Massachusetts landscape, framed by the Seven Sisters mountain range. I
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awoke days later in the ICU of a large city hospital that specializes in brain injury
patients. It was a near fatal fall from my bicycle, compounded by the bacteria we call
Lyme, that altered my personal future so significantly and negatively, forever changing
my quality of life. The grief was akin to losing my parents. Only now, 13 years later, has
my life settled a bit as remission visits me from time to time.
My anguish is what spurred me into action the only way I knew how—creating
awareness and change through research and writing. Hoping to make a difference, in
2016 I embarked on this journey to write a book with my colleague, which led me to
graduate school once again. Now six years later, with another completed dissertation, it is
my hope that my efforts will create the “tipping point” Gladwell speaks of—stimulating
others with the conviction that change is possible.
Living with chronic Lyme disease is a relentlessly difficult experience, but the
findings of this research also convey an important message about human potential. The
women represented in this dissertation, who deal with this disease on a daily basis,
struggling for life and livelihood, exhibit a profound strength of character. Although my
research did not specifically study coping mechanisms or the capacity to manage
significant life change, a constant thread running throughout is a deep and persistent
tenacity; their resilience, courage, adaptability, and self-advocacy offer a powerful
example of hope in the face of tremendous obstacles.
Anyone who becomes infected with chronic Lyme will need to find the spirit and
fortitude to survive and fight the kinds of injustices so clearly articulated by the women
in this study. Above all, they will need to become accustomed to a new—and perhaps
radically changed—life. It takes self-knowledge, dignity, and integrity to weather these
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extraordinarily turbulent storms. But I am inspired, because what I had the privilege to
witness throughout my work on this dissertation was a group of women who, even in the
face of acute illness and adversity, found ways to address significant challenges, fight
hardships, and advocate for themselves and others. The courage they demonstrate gives
me hope that positive change will come to pass for all those afflicted with Lyme.
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APPENDIX A
APPROVED INSTITUTIONAL REVIEW BOARD PROTOCOL

LETTER OF EXEMPT DETERMINATION
Date: March 18, 2021
To: Daniel Gerber and Dale Jones, Public Health
From: Professor Lynnette Leidy Sievert, Chair, University of Massachusetts
Amherst IRB
Protocol Title: Women and Lyme Disease
Protocol ID: 2560
Review Type: EXEMPT – NEW
Category: 2 Review Date: 03/18/2021
No Continuing Review Required
UM Award #:
The Human Research Protection Office (HRPO) has reviewed the above named
submission and has determined it to be EXEMPT from the federal regulations
that govern human subject research (45 CFR 46.104)
Note: This determination applies only to the activities described in this
submission. All changes to the submission (e.g. protocol, recruitment materials,
consent form, additional personnel), must be reviewed by HRPO prior to
implementation.
A project determined as EXEMPT, must still be conducted in accordance with the
ethical principles outlined in the Belmont Report: respect for persons,
beneficence, and justice. Researchers must also comply with all applicable
federal, state and local regulations as well as UMass Amherst Policies and
procedures which may include obtaining approval of your activities from other
institutions or entities. All personnel must complete CITI training.
Consent forms and study materials (e.g., questionnaires, letters, advertisements,
flyers, scripts, etc.) – Only use the consent form and study materials that were
reviewed by the HRPO.
Final Reports – Notify the IRB when your study is complete by submitting a Close
Request Form in the electronic protocol system.
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Serious Adverse Events and Unanticipated problems involving risks to
participants or others – All such events must be reported in the electronic system
as soon as possible, but no later than five (5) working days.
Annual Check In – HRPO will conduct an annual check in to determine the study
status.
Please contact the Human Research Protection Office if you have any further
questions.
Best wishes for a successful project.
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APPENDIX B
THE UGLY HISTORY OF LYME DISEASE
This appendix reviews the history of Borrelia burgdorferi, the bacterium
commonly known as Lyme disease. To fully appreciate the complexity, depth, and
magnitude of Lyme disease, its background, context, and evolution must be understood.

Early Evidence of Lyme Disease
According to Edlow (2004), in “1883 the German physician Alfred Buchwald
describes acrodermatitis chronica atrophans (ACA), the most chronic skin form of what
is now known to be part of Lyme disease” (p. xiv). This is commonly called the “Lyme
rash” by today’s medical professionals. Edlow recounts that, as early as 1910, in a report
by Swiss dermatologist Afzelius, “European sheep tick had been implicated” (p. 55) in
the transmission of Lyme. He also describes how in the spring and summer months of the
late 1800s, people in Europe were falling sick with and dying from an illness marked by
prominent red spots, which they called “tick fever” (p. 234). Could this have been the
now famous “bull’s-eye” rash that the medical establishment argues is typically the first
and most prominent sign of Lyme? (In fact, according to the International Lyme and
Associated Diseases Society’s “Lyme Disease Basics for Providers” (n.d., section:
Diagnosis of Lyme disease) less than 20% of all rashes have the classic bull’s-eye
appearance.)
Lyme disease was first identified in the United States in 1982, after a
concentration of cases came to light in Lyme, Connecticut. Polly Murray and her family
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were the first to be diagnosed, after she called attention to a cluster of people suffering
from similar symptoms.

Insects as a Tool of Biological Warfare
The scientist who identified the spirochete that causes Lyme disease was Wilhelm
Burgdorfer, after whom the bacterium is named. Burgdorfer has been implicated in the
development of Lyme infection as an instrument for biowarfare. Unfortunately, we must
remember that humanity has a long, ugly history of biological weapons development, as
demonstrated by Table 1B and Table 2B below.
Appendix B, Table 1: Use of biological agents as weapons (Riedel, 2004, p. 1)
Time

Event

1763

British distribute blankets from smallpox victims to Native Americans,
creating an epidemic among people with no prior exposure and thus no
resistance

1797

Napoleon floods the plains around Mantua, Italy, to attract mosquitos and
enhance the spread of malaria

World War II

Japan uses plague, anthrax, and other diseases against select
populations; several other countries experiment with and develop
biological weapons programs

1980-1988

Iraq uses mustard gas, sarin, and tabun against Iran and ethnic groups
inside Iraq during the Persian Gulf War

1995

Aum Shinrikyo uses sarin gas in the Tokyo subway system

113

Appendix B, Table 2: Biological agents used as bioweapons (Thavaselvam &
Vijayaraghavan, 2010, p. 1)
Agents
Bacteria
Ba. anthracis
Y. pestis
Br. melitensis
Br. abortus
Bu. mallei
Bu. pseudomallei
Viruses
Variola virus
Ebola virus
Marburg virus
Toxins
C. botulinum
Staphylococcus aureus
Ricin (plant)
Trichothecene (fungus)

Disease

Route of
Infection

Possible Release

Anthrax
Plague
Brucellosis

Aerosol
Aerosol
Aerosol

Spores
Vegetative cells
Vegetative cells

Glanders
Melioidosis

Aerosol
Aerosol

Vegetative cells
Vegetative cells

Smallpox
Ebola hemorrhagic fever
Marburg hemorrhagic
fever

Aerosol
Aerosol
Aerosol

Virus particles
Virus particles
Virus particles

Botulism

Ingestion
food/water
Food/water

Toxin

Food/water
Food/water

Toxin
Toxin

Staphylococcal enterotoxin type B (SEB)
Ricin Toxin
Trichothecene T2 toxin

Toxin

During World War II, Russians, Germans, and Americans all conducted extensive
research into bioweapons. According to Universitaet Tübingen (2014) (as reported in
Science Daily, a science research news platform), in January of 1942, Heinrich Himmler,
head of Hitler’s Schutzstaffel (the SS), engaged in creating a research institute to study
how insects infect humans, and how that knowledge could be turned to the advantage of
the Nazi regime. One focus, according to Dvorsky (2014), was research into how the
Nazis could use mosquitoes as biological weapons. In addition, the institute was ordered
to discover remedies against diseases transmitted by lice, mosquitos, and other small
insects (Carroll, 2004; Newby, 2019) because Germany had a severe problem with the
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number of troops plagued by typhoid due to poor sanitary conditions and tainted water
(Dvorsky, 2014).
After World War II, the United States and the Soviet Union entered a period of
hostility, tied to the perceived threat of communism and the escalation of nuclear
weapons. As Blakemore (2019) recounts, “between 1946-1991 the United States, the
Soviet Union, and their allies were locked in a long, tense conflict…. Though the
parties were technically at peace, the period was characterized by an aggressive arms
race, proxy wars, and ideological bids for world dominance” (section: introductory
statement). Globally, the political environment was one of mistrust and angst. As such,
“the Cold War was … not exclusively a struggle between the US and the USSR but a
global conflict that affected many countries, particularly the continent of Europe”
(University of Luxembourg, n.d., p. 3). Within the United States, fears abounded at all
levels that there were “adversaries among us,” damaging foreign policy and giving
military and atomic secrets to the Soviets.
We think about the Cold War in terms of the nuclear arms race, but the race to
develop bioweaponry was underway as well. Tim Weiner (1998), writing for the New
York Times, revealed that “Moscow’s cold war plans for World War III included
preparing hundreds of tons of anthrax bacteria and scores of tons of smallpox and plague
viruses” (p. 1). The United States was deeply engaged in biowarfare research as well,
including the weaponization of insects. For example, Newby (2019) documents that the
US air-dropped diseased ticks over Cuban sugar fields. Under the direction of President
Kennedy, there was a program named Operation Mongoose (previously named the Cuba
Project) to “get rid of Castro and the Castro regime (p. 62).
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Plum Island
Plum Island, only 840 acres in size and located just off the eastern coast of Long
Island, New York, was central to American bioweapons development. In 1897, the US
Army established a coastal artillery post, later known as Fort Terry, on the island.
Beginning in 1911, the facility was used for weapons and munitions storage. Fort Terry
was shifted to the US Department of Agriculture in 1954 (Carroll, 2004) and was closed
in the spring of 1995.
The biological weapons experimentation done on Plum Island was cloaked in an
atmosphere of obscurity, secrecy, and mystery. In fact, Plum Island is rarely even found
on maps; the map shown in Figure 1B is an exception.

Appendix B, Figure 1: Map of Plum Island, Stamped “ U.S. DEPT OF AGRICULTURE
(RESTRICTED) DANGEROUS ANIMAL DISEASES” (globalsecurity.org)
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As CBS News’ Morrow (2012) reported, “the very history of Plum Island—a post-WWII
Army biological weapons lab, the decades of secrecy and today’s tight security—all seem
to conspire to feed the rumors about what really goes on here” (24th paragraph). The US
government adamantly denies ever having done any dangerous research on the Island, but
the evidence is to the contrary. As recounted by Grossmann in Counterpunch (2013),
The Long Island daily newspaper Newsday earlier documented this biological
warfare mission of Plum Island. In a lead story on November 21, 1993, Newsday
investigative reporter John McDonald wrote: “A 1950s military plan to cripple the
Soviet economy by killing horses, cattle and swine called for making biological
warfare weapons out of exotic animal diseases at a Plum Island laboratory, nowdeclassified Army records reveal.” A facsimile of one of the records, dated 1951,
covered the front page of that issue of Newsday. (21st paragraph)
Two buildings on Plum Island, Building 101 and Building 257, were particularly
associated with animal and insect experimentation, and there is evidence that the
facility’s air circulation system was faulty. Carroll (2004) reported on details of
documents from 1975 stating that “several filter units had media improperly installed
with gaps up to three-quarters of an inch” (p. 103). If in fact the air ducts were faulty, this
would have allowed bacteria-infected ticks to escaped the lab. Then it is easy to see the
potential for them to attach themselves to the deer, mice, and birds on the island—which
is only two miles as the crow flies from Lyme, Connecticut.

Wilhelm Burgdorfer
Kris Newby is a science writer and narrative journalist. She and her family are
Lyme disease sufferers. Newby produced the film, Under Our Skin (2008), the first
documentary on chronic Lyme disease, the poor health care system, and the effects of
both. In Bitten: The Secret History of Lyme Disease and Biological Weapons (2019), she
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exposes Burgdorfer as not only the Lyme microbe’s discoverer but also as its developer.
She reveals that he developed bug-borne bioweapons during the Cold War, and that he
himself believed the Lyme epidemic was started by a military experiment gone wrong.
On his deathbed, Burgdorfer admitted his participation in the development of
Borrelia within ticks as a bioweapon. Newby (2019) writes, “shortly before his death
[November 17, 2014], Willy was videotaped saying that he believed that the outbreak of
tick-borne diseases that started around Lyme, Connecticut, had been caused by a
bioweapons release” (p. 17). Burgdorfer disclosed that the Lyme pathogen that was found
in the outbreak in Connecticut was the same pathogen as that with which he
experimented in 1952. As Newby recounts, he purposefully left out “essential data from
his scientific articles on the Lyme disease outbreak” as part of an intentional coverup,
adding that “this was a stunning admission from one of the world’s foremost authorities
on Lyme disease” (p. 101). Newby’s book contains photographs of Burgdorfer’s lab
reports, data, and declassified military documents.
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APPENDIX C
CDC HRQOL-14 “HEALTHY DAYS MEASURE”
The Centers for Disease Control and Prevention’s Health Related Quality of Life
instrument (2018a), which is reproduced on the following pages, includes three
components:
•

Healthy Days Core Module (4 questions)

•

Activity Limitations Module (5 questions)

•

Healthy Days Symptoms Module (5 questions)
The standard 4-item Healthy Days Core Module has been in the State-based

Behavioral Risk Factor Surveillance System since 1993. From 2000 to 2012, it has been
in the National Health and Nutrition Examination Survey for persons aged 12 and older.
Since 2003, it has been in the Medicare Health Outcome Survey, a measure in the
National Commission for Quality Assurance’s Healthcare Effectiveness Data and
Information Set.
The standard Activity Limitations and Healthy Days Symptoms Modules have
also been available since January 1995.
When used together, these three measures comprise the full CDC HRQOL-14
Measure.
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HEALTHY DAYS CORE MODULE
1. Would you say that in general your health is
Please Read
a. Excellent
b. Very good
c. Good
d. Fair
or
e. Poor

1
2
3
4
5

Do not read these responses
Don’t know/Not sure
Refused 9

7

2. Now thinking about your physical health, which includes physical illness and
injury, for how many days during the past 30 days was your physical health
not good?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

3. Now thinking about your mental health, which includes stress, depression,
and problems with emotions, for how many days during the past 30 days was
your mental health not good?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

If both Q2 AND Q3 = “None,” skip next question.
4. During the past 30 days, for about how many days did poor physical or
mental health keep you from doing your usual activities, such as self-care,
work, or recreation?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99
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ACTIVITY LIMITATIONS MODULE
These next questions are about physical, mental, or emotional problems or
limitations you may have in your daily life.
1. Are you LIMITED in any way in any activities because of any impairment or
health problem?
a. Yes
b. No

1
2

Don’t know/Not sure
Refused

7
9

If Q1 = “No,” “Don’t know/Not sure,” or “Refused,” go to Q1 of Healthy Days
Symptoms Module.
2. What is the MAJOR impairment or health problem that limits your activities?
Do Not Read. Code Only One Category.
a. Arthritis/rheumatism
b. Back or neck problem
c. Fractures, bone/joint injury
d. Walking problem
e. Lung/breathing problem
f. Hearing problem
g. Eye/vision problem
h. Heart problem
i. Stroke problem
j. Hypertension/high blood pressure
k. Diabetes
l. Cancer
m. Depression/anxiety/emotional problem
n. Other impairment/problem

01
02
03
04
05
06
07
08
09
10
11
12
13
14

Don’t know/Not sure
Refused

77
99
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3. For HOW LONG have your activities been limited because of your major
impairment or health problem?
Do Not Read. Code using respondent’s unit of time.
a. Days
b. Weeks
c. Months
d. Years

1__
2__
3__
4__

Don’t know/Not sure
Refused

777
999

4. Because of any impairment or health problem, do you need the help of other
persons with your PERSONAL CARE needs, such as eating, bathing,
dressing, or getting around the house?
a. Yes
b. No

1
2

Don’t know/Not sure
Refused

7
9

5. Because of any impairment or health problem, do you need the help of other
persons in handling your ROUTINE needs, such as everyday household
chores, doing necessary business, shopping, or getting around for other
purposes?
a. Yes
b. No

1
2

Don’t know/Not sure
Refused

7
9
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HEALTHY DAYS SYMPTOMS MODULE
1. During the past 30 days, for about how many days did PAIN make it hard for
you to do your usual activities, such as self-care, work, or recreation?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

2. During the past 30 days, for about how many days have you felt SAD, BLUE,
or DEPRESSED?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

3. During the past 30 days, for about how many days have you felt WORRIED,
TENSE, or ANXIOUS?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

4. During the past 30 days, for about how many days have you felt you did NOT
get ENOUGH REST or SLEEP?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99

5. During the past 30 days, for about how many days have you felt VERY
HEALTHY AND FULL OF ENERGY?
a. Number of Days
b. None

__
88

Don’t know/Not sure
Refused

77
99
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APPENDIX D
SURVEY CONSENT FORM AND INSTRUMENT
Consent
You have been invited to participate in this study because you are a member of
the Active Healing: Women and MSIDS. This form is called a Consent Form. It
will give you information about the study so you can make an informed decision
about participation in this research. Participants must be at least 18 years of age
and presently have or have had Lyme or a Lymelike disease to participate. We
are conducting this research study to examine the socialpsychological impacts
of Lyme and Lymelike Diseases (LLD). Participation will take place in one
session with an expected completion time of 1530 minutes.
Your participation in this research study is voluntary. You may choose not to
participate or not to answer individual questions. If you decide to participate in
this research survey, you may withdraw at any time without penalty.
If you agree to take part in this study, you will be asked to complete an online
survey. The survey questions will ask for demographic information. Participants
who are under 18 years of age or have never had Lyme or a Lymelike disease
will be excluded from survey participation. Those who meet the inclusion criteria
will be asked to assess how various statements relate to your personal
experience with Lyme or LLDs in aspects of your life including but not limited to
your place of employment, interpersonal relationships, and place of medical
care.
The results of this study will be used for scholarly purposes. This study will likely
benefit psychological and social understanding of Lyme and LLD and allow you
to gain insight into the research process. There will be no financial compensation
or direct benefit for participation in this study. Participation in this study can carry
psychological risk as questions are related to the impacts of Lyme Disease and
Lymelike Diseases on your personal life, social life, and workplace and may
elicit negative memories. There are no other known risks associated with
participation in this study. The following procedures will be used to protect the
confidentiality of your study records: Individual responses will be confidential and
files will be deidentified. Only the researchers, Caitlin Shea, Dale Jones and
Gretchen Rossman, will have access to the data. Names, birth dates, and
addresses will not be recorded. Responses will be averaged with others fitting
similar demographic profiles and the responses of sole individuals will not be
published. Any computer hosting electronic files will have password protection to
prevent access by unauthorized users and any physical copies will be kept in a
secure location.
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If you have questions about this project or if you have a researchrelated
problem, you may contact the researcher, Caitlin Shea at
bitten.contact@gmail.com or (413) 2059977. Research is being done under the
direct supervision of Dr. Gretchen Rossman who can be contacted at
gretchen@educ.umass.edu. If you have any questions concerning your rights as
a research subject, you may contact the University of Massachusetts Amherst
Human Research Protection Office (HRPO) at (413) 5453428 or
humansubjects@ora.umass.edu.
For further resources on Lyme Disease and Lymelike Diseases, you can
reference:
www.ilads.org
www.lymediseaseresource.com
www.lymediseaseassociation.org
In addition, each state government usually has a resource.

Clicking on the “agree” button below indicates the following:
By proceeding, I am agreeing to voluntarily enter this study. I have had a chance
to read this consent form, and it was explained to me in a language which I use
and understand. I have had the opportunity to ask questions and have received
satisfactory answers. I understand that I can withdraw at any time without
penalty.
I agree
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Demographics
What is your age? (Note: you must be at least 18 to take this survey)

What is your sex?
Male
Female
Intersex
What is your race?
Hispanic or Latinx
American Indian or Native Alaskan
Native Hawaiian or Other Pacific Islander
African American or Black
NonHispanic White Asian
What is your marital status?
Single
Committed relationship (nonmarried)
Married
Divorced
Widowed
From the options below select the option that best matches your religious
affiliation
Spiritual
Catholic
Christian
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Islamic
Atheist
Hindu
Jewish
Agnostic
Buddhist
Spiritual
What is your education level?
High School Diploma
Some College
Associate’s Degree
Bachelor’s Degree
Masters/PhD
Select the option that best matches your present employment status
Employed for wages
Selfemployed
Out of work and looking for work
Out of work and not currently looking for work
A student not employed
A student and employed (at least half time)
Retired
Unable to work
Other
What is your total annual household income?
Less than $10,000
$10,000 to $29,999
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$30,000 to $49,999
$50,000 to $74,999
$75,000 to $99,999
$100,000 to $149,999
$150,000 or more
In which country do you presently live?
The United States of America
Other

Lyme Background
Do you presently have Lyme or a LymeLike Disease (LLD)?
Yes, I have been medically diagnosed after one test
Yes, I have been medically diagnosed/tested after multiple
misdiagnoses
Yes, I have not been medically tested, but believe I have it
Yes, I have medically tested negative for Lyme, but believe that I
have it
No, I do not have Lyme or a LLD

Which test(s) were you diagnosed with/have you had?
ELISA
Western Blot
Comprehensive Testing (Igenex)
Clinically Diagnosed
PRC Test
Southern Blot
Other
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On a scale from 15 where 1 is “Rarely/Once every few months” and 5 is
“Multiple times a week”, mark the frequency with which you experience the
following symptoms because of Lyme or a LLD
Rarely/Once
Every Few
Months

Once a
Month

Every 2
Weeks

Every
Week

Multiple
Times a
Week

Fatigue
Nausea
Brain fog
Sleeplessness
Feelings of
depression
Head aches
Aching muscles
and joints
On a scale from 15 where 1 is “Mild” and 5 is “Severe,” mark the severity in
which you experience the following symptoms because of Lyme or a LLD
1-Mild

2

Fatigue
Nausea
Brain fog
Sleeplessness
Feelings of
depression
Head aches
Aching muscles
and joints
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3

4

5-Severe

Why have you not been tested? Select all that apply
I cannot afford to go to a doctor or hospital
I do not know any doctors or hospitals specialized in Lyme or LLDs
My doctor refuses to test me
Other
Why do you not trust the medical diagnosis?
I believe the leading tests for Lyme are ineffective and inaccurate
The doctor appeared to know little about Lyme and LLDs
I still present symptoms that indicate an active Lyme infection
Other
Do you go to a doctor who is specialized in Lyme or LLDs?
Yes
No
Why did you choose to go to a specialized doctor?
My primary care was not sufficiently knowledgeable about Lyme
My primary care did not meet my specific needs
My primary care dismissed my symptoms
Other
Why didn’t you go to a doctor specialized in Lyme?
My primary care adequately addresses my medical needs
I cannot afford a specialized doctor
I cannot find a specialized doctor that is accessible to me
Other
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Check all that apply
I feel like it took a long time to be diagnosed with Lyme or a LLD
I often feel like my symptoms are invalidated by the medical field
I’ve looked for alternative medicines to treat my Lyme or LLD
I have had difficulty finding a Lyme literate doctor
With regards to medical affordability, check all that apply
I have difficulty affording medication
I have difficulty affording copays and specialists
I can afford my medications
I can afford my copays and specialists

Treatment and Medicine
Regarding your primary care, on a scale from 15 where 1 is “I strongly disagree”
and 5 is “I strongly agree,” mark the degree to which you agree with the following
statements
Strongly Somewhat
disagree disagree
My primary care
doctor is
knowledgeable about
Lyme or LLDs
My primary care
doctor was able to
quickly identify my
symptoms and
diagnose Lyme or
LLD
My medical bills are
affordable
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Neither
agree
Somewhat Strongly
nor
agree
agree
disagree

My primary care
doctor knows
numerous treatment
options
My primary care
doctor was able to
refer me to many
helpful treatment
options or outside
consultants
I trust the medical
industry overall
I trust the medical
industry in its ability
to diagnosis and treat
Lyme or LLDs
I trust my primary
care doctor
There are many
treatment options for
Lyme Disease or
LLDs
Lyme Disease and
LLDs is well
researched
I believe that Lyme
and LLDs are taken
seriously within the
medical industry
My primary care is
able to treat me
without the help of
outside consultants
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I trust traditional
medicine
I trust nontraditional
treatments

I have an advocate who accompanies me on medical visits
Yes
No
At the time of seeking a diagnosis
My insurance covered treatment (doctor visits, medications, etc)
My insurance did not cover treatment (doctor visits, medications, etc)
I was able to afford expenses out of pocket
I was not able to afford my expenses out of pocket
I did not have insurance
At the time of treatment
I was insured
I was not insured
I was able to afford expenses out of pocket
I am not able to afford my expenses out of pocket

Presently,
I have health insurance
I do not have health insurance
I am able to afford expenses out of pocket
I am not able to afford my expenses out of pocket
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If you are/were insured, how much of your diagnostic expenses did your
insurance cover (bloodwork, xrays, etc)?
most of my diagnostic expenses
roughly half of my diagnostic expenses
very few of my diagnostic expenses
none of my diagnostic expenses
not applicable
If you are/were insured, how long did your insurance cover diagnostic testing?
2 weeks
3 months
6 months
more than a year
not applicable
If you are/were insured, how long did your insurance cover medication?
2 weeks
3 months
6 months
more than a year
not applicable
If you are/were insured, during the time of coverage, how much of your treatment
expenses did your insurance cover (doctor visits, medications, etc)?
2 weeks
3 months
6 months
more than a year
not applicable
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Check all that apply. My insurance covered the following tests:
ELISA
Western Blot
Comprehensive Testing (Igenex)
Clinically Diagnosed
PRC Test
Southern Blot
Other
My insurance did not cover testing

If you had to guess, approximately how much would you say you spent in finding
a diagnosis and treatment? Please include outofpocket costs only in whole US
dollars (i.e., do not include costs covered by insurance).

Specialized Care
Regarding your Lyme or LLD specialized doctor, on a scale from 15 where 1 is “I
strongly disagree” and 5 is “I strongly agree,” mark the degree to which you
agree with the following statements
Strongly
disagree

Somewhat
disagree

My specialized
doctor is
knowledgeable
about Lyme or
LLDs
My specialized
doctor is affordable
I trust my
specialized doctor
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Neither
agree
nor
disagree

Somewhat
agree

Strongly
agree

My specialized
doctor knows of
more treatment
options than my
primary care
My specialized
doctor is accessible

Social Sphere
Regarding your interpersonal relationships, on a scale from 15 where 1 is “I
strongly disagree” and 5 is “I strongly agree,” mark the degree to which you
agree with the following statements

I believe that Lyme
and LLDs are taken
seriously by my
friends and family

Neither
Strongly Somewhat
agree
Somewhat Strongly
disagree disagree
nor
agree
agree
disagree

My friends and family
are knowledgeable
about Lyme disease
and LLDs
My friends and family
view me differently
since being
diagnosed with Lyme
and LLDs
I am emotionally
supported by my
friends and family
I can count on my
friends and family to
bring me to the doctor

136

I can count on my
friends and family to
help me with
treatment (e.g.
picking up medicine)
My friends and family
understand the
severity of my Lyme
or LLD
My friends and family
understand how
Lyme/LLDs impact
my life
My friends and family
are sympathetic
about my Lyme/LLD
Lyme/LLDs have
negatively impacted
my close personal
relationships
I am comfortable
telling people in my
life about my
Lyme/LLD status
I am comfortable
telling new people in
my life about my
Lyme/LLD status
I feel stigmatized
among friends and
family because of my
Lyme/LLD
Some people have
pulled away from me
since I’ve told them
about my Lyme/LLD
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I feel like there are
many people I can go
to for help regarding
my Lyme/LLD
I feel confident in my
own capabilities to
make decisions
regarding my care
Regarding your interpersonal relationships, on a scale from 15 where 1 is “I
strongly disagree” and 5 is “I strongly agree,” mark the degree to which you
agree with the following statements
Strongly
disagree

Somewhat
disagree

I ask my friends or
family for help
regarding
Lyme/LLD
treatment (e.g.
taking me to the
doctor)
I discuss treatment
decisions with
friends and families
I tell my friends and
family about my
health
I disclose my
Lyme/LLD status to
new romantic
partners
I tell new
acquaintances
about Lyme/LLDs
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Neither
agree
nor
disagree

Somewhat
agree

Strongly
agree

I turn to friends and
family for emotional
support for my
Lyme/LLD
I educate friends
and family on Lyme
and/or LLDs
I ask friends and
family for help when
I’m ill
I share my day to
day experience with
Lyme/LLDs with
many people

Workplace
Regarding your workplace, on a scale from 15 where 1 is “I strongly disagree”
and 5 is “I strongly agree,” mark the degree to which you agree with the following
statements
Strongly Somewhat
disagree disagree
My boss is
sympathetic to the
symptoms of my
Lyme/LLD
My Lyme/LLD does
not interfere with my
job
I take additional time
off because of the
symptoms of
Lyme/LLD
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Neither
agree
Somewhat Strongly
nor
agree
agree
disagree

My boss is
understanding of my
Lyme/LLD and lets
me take time off when
needed
My workplace has
adjusted the
requirements of my
position to be more
Lyme/LLD friendly
I am limited in where I
can work because of
my Lyme/LLD
I am limited in what I
can do because of my
Lyme/LLD
I am afraid of taking
the time off I should
because of my
Lyme/LLD
My coworkers do not
acknowledge or
validate my illness
I believe that
Lyme/LLDs are taken
seriously within my
workplace
My coworkers do not
treat Lyme/LLDs like
a disorder that can
impair my ability to do
certain tasks
I often try to “work
through” Lyme/LLD
symptoms even at a
detriment to my
health

140

Invisible Illness
Regarding your Lyme or LLD, on a scale from 15 where 1 is “I strongly disagree”
and 5 is “I strongly agree,” mark the degree to which you agree with the following
statements
Strongly Somewhat
disagree disagree
I feel like Lyme
disease and LLDs are
an invisible illness

Neither
agree
Somewhat Strongly
nor
agree
agree
disagree

My Lyme disease or
LLD is chronic
The symptoms of my
Lyme disease or LLD
are severe

Powered by Qualtrics
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APPENDIX E
FOCUS GROUP CONSENT FORM AND QUESTIONS
You have been invited to participate in this study because you have indicated
that you have Lyme disease. This is a consent form. It will provide you with the
information you need to make an informed decision to participate in this
research. Participants must be women, 18 years of age and presently have Lyme
or Lyme like disease (LLD). Participation will take 1.5 hours. If you decide to
participate you will be asked to sign this form and/or give verbal consent.
Your participation in the focus group is voluntary. You may choose not to
participate at any time. You may choose not to answer any question(s) that are
uncomfortable for you. You may withdraw your participation at any time without
penalty.
The focus group session will be held via Zoom due to global pandemic of Covid19. There will be 6-10 participants. If you agree to take part in the focus group
research, you will be asked to answer 3-5 questions on your personal experience
with Lyme disease, and write your responses on paper to be submitted to the
moderator. For example, you may be asked to write about your visits to a Lyme
specialist doctor. Additionally, you will be asked to submit your personal narrative
on your overall Lyme disease experiences to augment the focus group
discussion. The answers you provide will not be identified by name. The
researcher, Dr. Dale M. Jones will be the only person to review and tabulate your
responses.
The results of the focus groups and narratives will be used for scholarly
purposes. This study will most likely be of benefit to you in understanding the
economic and social impacts of Lyme and LLDs for women and allow you to gain
insight into the research process. This study will advance research to better
understand the complexities for women living with Lyme and LLDs. There will be
no financial compensation or direct benefit for participation in this study.
Participation in this study can carry psychological risk as questions related to the
impact that Lyme disease and LLDs have on your life and may elicit negative
memories. There are no other known risks to participation in this study. In order
to minimize risk, the participants will be provided the questions before the group
meet, allowing for withdrawal from participation if the questions are
uncomfortable. Support for Lyme disease can be found at www.lymedisease.org.
Please note: Massachusetts law requires ALL members of a convened group to
agree for their responses to be audio-recorded.
Do not share the focus group discussions with anyone outside of the group.
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Any sharing of information outside of this focus group session will be considered
a data breach.
Please be advised that although the researchers will take every precaution to
maintain confidentiality of the data, the nature of the focus group prevents the
researcher from guaranteeing confidentiality. The researcher would like to remind
participants to respect the privacy of your fellow participants and not repeat what
is said in the focus group to others.
The following procedures will be used to protect the confidentiality of your study
records: individual responses will be confidential, and files will not be identified.
Documents will be collected without identifiers. Only the researcher Dr. Dale M.
Jones, will have access to the data. No identifying information will be collected.
Names, birthdates, and addresses will not be asked for or recorded. There is
always a marginal chance that a breach of confidentiality can occur.
Any computer hosting electronic files will be password protected to prevent
access by unauthorized users and any physical copies will be kept in a secure
location. If you have questions about this project you may contact Dr. Jones
directly at dmjones@umass.edu. If you have questions about your rights as a
research subject, you may contact the University of Massachusetts Amherst
Human Research Protection Office (HRPO) at (413) 545-3428, or
humansubjects@ora.umass.edu.
I hereby grant and assign to the Researcher/Author and their licensees,
successors, and assign the following rights in connection with the Interview
Materials for use as part of the Work or any derivative material including but not
limited to advertising, packaging, or promotional materials for the Work,
presentations, in any and all editions, versions, and media, in perpetuity and
throughout the world.
1. I acknowledge that the statements and words submitted are my own and do
not belong to others and that I hereby take legal and financial responsibility if the
statements I submit misrepresent and appropriate of already published and
copyright materials that do not belong to me.
2. The right to quote, paraphrase, and edit for clarity all or any portion of the
Interview Materials, and to generally use and publish the Interview Materials,
including my experiences, recollections, incidents, remarks, dialogue, actions,
and information, as well as any photographs and documents that I may give to
the Authors.
3. The right to use my name, image, and biographical data unless otherwise
stated prior to my interview or text submission.
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4. I understand that I may be contacted to expand upon, clarify, or add additional
context to the work I submit. I hereby consent to the same terms outlined in this
form with regard to any continuing dialogues or submission unless otherwise
stated prior to responding.
5. The right to develop, produce, distribute, advertise, promote, or otherwise
exploit the Work as a book or any other Work in any manner that the
Researcher/Author assigns deems appropriate. I understand and acknowledge
that the Researcher/Author or whomever they assign will be the sole owner of all
copyright and other rights in and to the Work. In order to enable the
Researcher/Author to develop the Work in any manner that the
Researcher/Author may deem best, I hereby release and discharge the
Researcher/Author and their licensees, successors, and assigns, from any and
all financial, legal, and other claims, demands, or causes of action that I may
have against them by reason of anything contained in the Work, or any of the
above uses, including any claims based on the right of privacy, the right of
publicity, copyright, libel, defamation, or any other right. I acknowledge and agree
that I am not entitled to receive any form of payment from the Author and/or their
licensees, successors, and assigns.
6. I acknowledge that I may not be published in the Work or any other derivative
materials.
Agreed and confirmed (consent to be considered granted upon submission of a
story through either the form above or if emailed directly to
dmjones@umass.edu).
When signing this form, I am agreeing to voluntarily enter this study. I have had a
chance to read this consent form, and it was explained to me in a language I use.
I have had the opportunity to ask questions and have revived satisfactory
answers. I have been informed that I can withdraw at any time. A copy of this
signed informed consent form has been given to me.
I agree to maintain the confidentiality of the information discussed by all
participants and researchers during the focus group session.

_____________________
Participant Signature

_______________
Print Name
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____________
Date

By signing below, I indicate that the participant has read and, to the best of my
knowledge understands the details contained in this document and has been
given a copy.

_____________________
Signature of person
obtaining consent

_______________
Print Name

____________
Date

FOCUS GROUP QUESTIONS
FOR ALL GROUPS
Discussion of research participation; anonymity and confidentiality (repeat at every
group).
Review and sign consent form.
(At the end of session) Please write a one page synopsis of your personal journey with
Lyme disease. Focus on the following 5 themes.
1.
2.
3.
4.
5.

Diagnosis (length, how, when, what happened)
Relationships (partner, friends, family, work, medical)
Medical Struggles (misdiagnosis, treatment, doctors)
Work Ability (work support, days off, can you work, did work know)
Access to Treatment (financial, physical, barriers)

FOR INDIVIDUAL FOCUS GROUPS
Focus Group 1: Road to Diagnosis
To the best of your recollection…
How long did it take to get diagnosed and why?
Provide a timeline of your medical journey pre diagnosis. Please list the dates, times and
symptoms you sought treatment for. What other diagnoses were you given?
Provide a timeline post diagnosis. Please list the dates, times, appointments and
symptoms you sought treatment for.
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Focus Group 2: Relationships and Support
How has your illness affected your relationships (any and all)?
Describe your primary relationship(s) and how that may have changed after diagnosis?
What kind of support were you able to access?
-

Financial
Emotional (therapy)
Logistical
Physical
Spiritual
Other

Where did that support come from?
-

Friends
Family
Church
Therapists
Workplace
Professionals
Other

Focus Group 3: Medical Struggles
Describe in detail your experiences with the following (please map):
Doctors; include specialists.
Diagnosis by said doctors.
Treatment successes or challenges.
Alternative methods and treatments sought.
Focus Group 4: Work Ability
Describe your working ability pre diagnosis and post diagnosis.
How did/does Lyme effect your ability to work?
Have you had to change careers or leave your job?
Focus Group 5: Access to Treatment
Has your health insurance or lack of health insurance hindered your ability to get
treatment? If so how?
How has your overall financial status affected your ability to receive treatment? If so
how?
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APPENDIX F
NARRATIVE CONSENT FORM AND PROMPTS
I understand that Gretchen Rossman, and Dale Jones (the Authors) are
preparing, writing, and will publish a work on the subject of Lyme Disease, which
is currently titled Bitten by Lyme (the Work).
In order to assist the Authors in the preparation of the Work, I have agreed to
submit a statement and potentially be interviewed and to provide information and
other materials to be used in connection with the Work, including my personal
experiences, remarks, and recollections as well as any photographs and
documents that I may choose to give to the Author (the Interview Materials).
I hereby grant and assign to the Authors and their licensees, successors, and
assign the following rights in connection with the Interview Materials for use as
part of the Work or any derivative material including but not limited to advertising,
packaging, or promotional materials for the Work, presentations, in any and all
editions, versions, and media, in perpetuity and throughout the world.
1. I acknowledge that the statements and words submitted are my own and do
not belong to others and that I hereby take legal and financial responsibility if the
statements I submit misrepresent and appropriate of already published and
copyright materials that do not belong to me.
2. The right to quote, paraphrase, and edit for clarity all or any portion of the
Interview Materials, and to generally use and publish the Interview Materials,
including my experiences, recollections, incidents, remarks, dialogue, actions,
and information, as well as any photographs and documents that I may give to
the Authors.
3. The right to use my name, image, and biographical data unless otherwise
stated prior to my interview or text submission.
4. I understand that I may be contacted to expand upon, clarify, or add additional
context to the work I submit. I hereby consent to the same terms outlined in this
form with regard to any continuing dialogues or submission unless otherwise
stated prior to responding.
5. The right to develop, produce, distribute, advertise, promote, or otherwise
exploit the Work as a book or any other Work in any manner that the Authors
assigns deems appropriate. I understand and acknowledge that the Authors or
whomever they assign will be the sole owner of all copyright and other rights in
and to the Work. In order to enable the Authors to develop the Work in any
manner that the Authors may deem best, I hereby release and discharge the
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Authors and their licensees, successors, and assigns, from any and all financial,
legal, and other claims, demands, or causes of action that I may have against
them by reason of anything contained in the Work, or any of the above uses,
including any claims based on the right of privacy, the right of publicity, copyright,
libel, defamation, or any other right. I acknowledge and agree that I am not
entitled to receive any form of payment from the Authors and/or their licensees,
successors, and assigns.
6. I acknowledge that I may not be published in the Work or any other derivative
materials.
Agreed and confirmed (consent to be considered granted upon submission of a
story through either the form above or if emailed directly to
bitten.contact@gmail.com)

NARRATIVE STORY PROMPTS
(www.bittenbylyme.com)
Lyme is a sometimes chronic illness that can greatly impact the lives of those who have
it. Bitten by Lyme is a social inquiry exploring how living with Lyme or a Lyme-like
Disease (LLD) can affect the various aspects of one’s life, from social relationships to the
workplace. While Bitten is guided by research, it will feature stories from those most
affected. We hope to gather and share narratives that illustrate the trends found from the
survey.
We want to hear from you, the Lyme community, about how Lyme or a Lyme-like
Disease has impacted your life. We ask that submissions are limited to roughly one typed
page and focus on one or some of the following:
•

How your illness has affected your relationships with family and friends

•

How you share your illness and/or medical struggles with your family and friends

•

How your illness has affected your ability to work and your relationships in the
workplace

•

Your experiences interacting with the medical profession (diagnosis, treatment,
specialized doctors and/or alternative treatment)

•

How your access to health insurance and your financial status have affected your
ability to receive treatment

•

If you are living with a spouse or domestic partner, how has that affected your
ability to manage your illness (treatment, financial resources, emotional support)
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APPENDIX G
REPORT OF PRELIMINARY FINDINGS
SUMMARY OF SURVEY ANALYSIS
Amanda Gorham, 25 February 2019
The following report summarizes the results of a survey administered to nearly 400
women over the age of 18, residing in the United States. Participants were recruited from
a Lyme/Lyme-related disease (LLD)-focused Facebook group, including over 18,000
active members. This social media group is specifically catered to women who have been
affected by Lyme and/or LLDs internationally. The resulting sample was predominantly
white (95.9%), ranged from age 19 to 80, and claimed to be in partnered relationships
(73.2%). Proportionally more women in the sample reported annual household income
greater than $100,000 (30.8%).
The use of a doctor specialized in Lyme and LLDs appears to be a privilege, as evidenced
by the high education level and household income level specific to the portion of the
sample that made use of a specialized doctor, in comparison to those who relied only on
their primary care doctor. It seems that specialized care may have an important
relationship with managing the demands of the workplace, as well as general awareness
of more treatment options. Respondents reported affordability as a barrier to accessing
specialized care, but those who were able to receive this kind of care had more trust in
their doctors.
Overwhelmingly, Lyme Disease and LLDs were reported to be insufficiently researched
and not taken seriously by the medical industry. These opinions are supported by
respondents report of lacking healthcare coverage and inaccurate and/or drawn out
diagnosis.
Overall, it seems that respondents have experienced an impact to their social and work
identities. Feeling stigmatized and like there is no one to go to for support were common
reports. The workplace was found to be mostly unsupportive in accommodating unique
needs of those with Lyme/LLDs and many survey participants reported working through
their symptoms, even at a detriment to their own health. One could wonder if this is a
result of the workplace climate or an underlying personality trait that drives respondents
to work in this way.
Income was significantly different between symptom groups (Fewer and Less, More and
More). Those with fewer and less severe symptoms reported large household incomes
(mostly at or above $100,000), while those with more and more severe symptoms
reported household incomes at or below $29,999 most commonly. As one might expect,
those with higher income tend to have reported a higher education level. These results
could be a result of higher education levels leading to higher income levels; however, one
could also wonder if Lyme has impacted people both financially and educationally (i.e.,
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because of Lyme, persons are unable to continue their education to higher levels and, as a
result, earn a lower income.
With a larger sample size, regression analyses could be performed to investigate the
relationship between predictors (e.g., health care system satisfaction, age, household
income) and a dependent variable, or outcome (e.g., use of specialized doctor). This
would provide a clearer interpretation of many research questions, such as those listed
here:
•
•

Does household income impact use of specialized doctor more than education
level?
As symptom severity increases, how do interpersonal relationships change?

Statistical procedures used for this report include crosstabulations, chi-square tests for
significance, t-tests, and one-way ANOVA. These analyses are explained here for use by
the research team.
•
•

•

•

Crosstabulation: A descriptive analysis of how respondent’s answer selections
overlap between items (i.e., How many respondents who used a specialized doctor
reported trusting the healthcare system overall?).
Chi-square: a test of statistical significance. In the social sciences, a chi-square
equal to or less than 0.05 is considered statistically significant. In this report, chisquare tests were used to report the likelihood that the findings, reported in
crosstabulations (crosstabs), were not merely due to chance. The research team
should use caution when interpreting this metric, especially in the case of layered
crosstabs (“____ by ____ within _____”), as this statistic does not indicate where
the statistically significant difference is within the table or group (i.e., the findings
overall are significant, but we don’t know which differences are actually
significant).
T-test: this statistical procedure tests for differences in means between two
groups, based on one attribute of interest, such as age. A statistically significant ttest indicates that, on average, there is a difference between groups that is not
likely due to chance.
One-Way ANOVA: This type of Analysis of Variance evaluates the differences in
the means of more than two groups, based on one attribute of interest, such as age.
For this report, a one-way ANOVA is used to evaluate the mean differences
between income level groups (3 groups). A statistically significant one-way
ANOVE indicates that, on average, there is a difference between groups that is
not likely due to chance.
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